Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in J Antimicrob Chemother

Retrieve available abstracts of 454 articles:
HTML format



Single Articles


    July 2021
  1. MCMURTRY TA, Barekat A, Rodriguez F, Purewal P, et al
    Capability of Enterococcus faecalis to shield Gram-negative pathogens from aminoglycoside exposure.
    J Antimicrob Chemother. 2021 Jul 10. pii: 6318623. doi: 10.1093.
    PubMed     Abstract available


  2. ASEMPA TE, DeRosa NA, Cassino C, Lehoux D, et al
    Efficacy assessment of lysin CF-296 in addition to daptomycin or vancomycin against Staphylococcus aureus in the murine thigh infection model.
    J Antimicrob Chemother. 2021 Jul 5. pii: 6314896. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  3. KRUGER H, Ji X, Wang Y, Fessler AT, et al
    Identification of Tn553, a novel Tn554-related transposon that carries a complete blaZ-blaR1-blaI beta-lactamase operon in Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jun 24. pii: 6308652. doi: 10.1093.
    PubMed    


  4. SATISHKUMAR N, Alexander JAN, Poon R, Buggeln E, et al
    PBP4-mediated beta-lactam resistance among clinical strains of Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6307153. doi: 10.1093.
    PubMed     Abstract available


  5. PINHOLT M, Mollerup S, Boye K, Worning P, et al
    Investigation of the introduction and dissemination of vanB Enterococcus faecium in the Capital Region of Denmark and development of a rapid and accurate clone-specific vanB E. faecium PCR.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6306968. doi: 10.1093.
    PubMed     Abstract available


  6. HANAO M, Aoki K, Ishii Y, Shimuta K, et al
    Molecular characterization of Neisseria gonorrhoeae isolates collected through a national surveillance programme in Japan, 2013: evidence of the emergence of a ceftriaxone-resistant strain from a ceftriaxone-susceptible lineage.
    J Antimicrob Chemother. 2021;76:1769-1775.
    PubMed     Abstract available


  7. NOBREGA DE ALMEIDA J, Francisco EC, Holguin Ruiz A, Cuellar LE, et al
    Epidemiology, clinical aspects, outcomes and prognostic factors associated with Trichosporon fungaemia: results of an international multicentre study carried out at 23 medical centres.
    J Antimicrob Chemother. 2021;76:1907-1915.
    PubMed     Abstract available


  8. ZHANEL GG, Adam HJ, Baxter M, Lagace-Wiens PRS, et al
    In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).
    J Antimicrob Chemother. 2021;76:1808-1814.
    PubMed     Abstract available


  9. SIERRA Y, Gonzalez-Diaz A, Carrera-Salinas A, Berbel D, et al
    Genome-wide analysis of urogenital and respiratory multidrug-resistant Haemophilus parainfluenzae.
    J Antimicrob Chemother. 2021;76:1741-1751.
    PubMed     Abstract available


  10. SLIMINGS C, Riley TV
    Antibiotics and healthcare facility-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update.
    J Antimicrob Chemother. 2021;76:1676-1688.
    PubMed     Abstract available


  11. DE KORNE-ELENBAAS J, Bruisten SM, de Vries HJC, Van Dam AP, et al
    Emergence of a Neisseria gonorrhoeae clone with reduced cephalosporin susceptibility between 2014 and 2019 in Amsterdam, The Netherlands, revealed by genomic population analysis.
    J Antimicrob Chemother. 2021;76:1759-1768.
    PubMed     Abstract available


  12. LE TURNIER P, El Helali N, Guilhaumou R, Pilmis B, et al
    CSF concentration of cefotaxime in adult patients with pneumococcal meningitis: a multicentre retrospective study.
    J Antimicrob Chemother. 2021 Jun 13. pii: 6297842. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  13. BERBEL D, Camara J, Gonzalez-Diaz A, Cubero M, et al
    Deciphering mobile genetic elements disseminating macrolide resistance in Streptococcus pyogenes over a 21 year period in Barcelona, Spain.
    J Antimicrob Chemother. 2021 May 20. pii: 6279207. doi: 10.1093.
    PubMed     Abstract available


  14. SABAT AJ, Bathoorn E, Becker K, Akkerboom V, et al
    Staphylococcal cassette chromosome mec containing a novel mec gene complex, B4.
    J Antimicrob Chemother. 2021 May 15. pii: 6276546. doi: 10.1093.
    PubMed     Abstract available


  15. SUGAWARA Y, Hagiya H, Akeda Y, Takeuchi D, et al
    Community spread and acquisition of clinically relevant Escherichia coli harbouring blaNDM among healthy Japanese residents of Yangon, Myanmar.
    J Antimicrob Chemother. 2021;76:1448-1454.
    PubMed     Abstract available


  16. GALARION LH, Mohamad M, Alzeyadi Z, Randall CP, et al
    A platform for detecting cross-resistance in antibacterial drug discovery.
    J Antimicrob Chemother. 2021;76:1467-1471.
    PubMed     Abstract available


  17. FRISCH S, Boese A, Huck B, Horstmann JC, et al
    A pulmonary mucus surrogate for investigating antibiotic permeation and activity against Pseudomonas aeruginosa biofilms.
    J Antimicrob Chemother. 2021;76:1472-1479.
    PubMed     Abstract available


  18. NAIR S, Chattaway M, Langridge GC, Gentle A, et al
    ESBL-producing strains isolated from imported cases of enteric fever in England and Wales reveal multiple chromosomal integrations of blaCTX-M-15 in XDR Salmonella Typhi.
    J Antimicrob Chemother. 2021;76:1459-1466.
    PubMed     Abstract available


  19. VAN KLEEF E, Wielders CCH, Schouls LM, Feenstra SG, et al
    National point prevalence study on carriage of multidrug-resistant microorganisms in Dutch long-term care facilities in 2018.
    J Antimicrob Chemother. 2021;76:1604-1613.
    PubMed     Abstract available


  20. BRANDIS G, Gockel J, Garoff L, Guy L, et al
    Expression of the qepA1 gene is induced under antibiotic exposure.
    J Antimicrob Chemother. 2021;76:1433-1440.
    PubMed     Abstract available


  21. KARCZEWSKI J, Brown CM, Maezato Y, Krasucki SP, et al
    Efficacy of a novel lantibiotic, CMB001, against MRSA.
    J Antimicrob Chemother. 2021;76:1532-1538.
    PubMed     Abstract available


  22. PARSELS KA, Mastro KA, Steele JM, Thomas SJ, et al
    Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections.
    J Antimicrob Chemother. 2021;76:1379-1391.
    PubMed     Abstract available


  23. BRIGGS S, Broom M, Duffy E, Everts R, et al
    Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditis.
    J Antimicrob Chemother. 2021 May 11. pii: 6274254. doi: 10.1093.
    PubMed     Abstract available


  24. NOEL AR, Attwood M, Bowker KE, MacGowan AP, et al
    The pharmacodynamics of minocycline alone and in combination with rifampicin against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection.
    J Antimicrob Chemother. 2021 May 11. pii: 6274253. doi: 10.1093.
    PubMed     Abstract available


  25. ADAMECZ Z, Nielsen KL, Kirkby NS, Frimodt-Moller N, et al
    Aminoglycoside resistance genes in Enterococcus faecium: mismatch with phenotype.
    J Antimicrob Chemother. 2021 May 9. pii: 6272857. doi: 10.1093.
    PubMed    


  26. WANG W, Sun B
    VraCP regulates cell wall metabolism and antibiotic resistance in vancomycin-intermediate Staphylococcus aureus strain Mu50.
    J Antimicrob Chemother. 2021 May 5. pii: 6264898. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  27. DEJOIES L, Sassi M, Schutz S, Moreaux J, et al
    Genetic features of the poxtA linezolid resistance gene in human enterococci from France.
    J Antimicrob Chemother. 2021 Apr 25. pii: 6251856. doi: 10.1093.
    PubMed     Abstract available


  28. PUTSATHIT P, Hong S, George N, Hemphill C, et al
    Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
    J Antimicrob Chemother. 2021 Apr 25. pii: 6250920. doi: 10.1093.
    PubMed     Abstract available


  29. BOEKHOUD IM, Sidorov I, Nooij S, Harmanus C, et al
    Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile.
    J Antimicrob Chemother. 2021 Apr 20. pii: 6239454. doi: 10.1093.
    PubMed     Abstract available


  30. WALKER SV, Wolke M, Plum G, Weber RE, et al
    Failure of Vitek2 to reliably detect vanB-mediated vancomycin resistance in Enterococcus faecium.
    J Antimicrob Chemother. 2021 Apr 14. pii: 6225960. doi: 10.1093.
    PubMed     Abstract available


  31. LU CH, Shiau CW, Chang YC, Kung HN, et al
    SC5005 dissipates the membrane potential to kill Staphylococcus aureus persisters without detectable resistance.
    J Antimicrob Chemother. 2021 Apr 14. pii: 6225957. doi: 10.1093.
    PubMed     Abstract available


  32. MASON CY, Kanitkar T, Richardson CJ, Lanzman M, et al
    Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics.
    J Antimicrob Chemother. 2021;76:1323-1331.
    PubMed     Abstract available


  33. BRILHANTE M, Gobeli Brawand S, Endimiani A, Rohrbach H, et al
    Two high-risk clones of carbapenemase-producing Klebsiella pneumoniae that cause infections in pets and are present in the environment of a veterinary referral hospital.
    J Antimicrob Chemother. 2021;76:1140-1149.
    PubMed     Abstract available


  34. UNEMO M, Ahlstrand J, Sanchez-Buso L, Day M, et al
    High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018.
    J Antimicrob Chemother. 2021;76:1221-1228.
    PubMed     Abstract available


  35. NOBREGA D, Peirano G, Lynch T, Finn TJ, et al
    Spatial distribution of Escherichia coli ST131 C subclades in a centralized Canadian urban region.
    J Antimicrob Chemother. 2021;76:1135-1139.
    PubMed     Abstract available


  36. MARIN JEO, Villatoro E, Luna MJ, Barrientos AM, et al
    Emergence of MDR invasive Neisseria meningitidis in El Salvador, 2017-19.
    J Antimicrob Chemother. 2021;76:1155-1159.
    PubMed     Abstract available


  37. LEE IR, Thein TL, Ang LW, Ding Y, et al
    Cefazolin versus ceftriaxone as definitive treatment for Klebsiella pneumoniae bacteraemia: a retrospective multicentre study in Singapore.
    J Antimicrob Chemother. 2021;76:1303-1310.
    PubMed     Abstract available


  38. FIFER H, Livermore DM, Uthayakumaran T, Woodford N, et al
    What's left in the cupboard? Older antimicrobials for treating gonorrhoea.
    J Antimicrob Chemother. 2021;76:1215-1220.
    PubMed     Abstract available


  39. PAI MP, Wilcox MH, Chitra S, McGovern PC, et al
    Safety and efficacy of omadacycline by BMI categories and diabetes history in two Phase III randomized studies of patients with acute bacterial skin and skin structure infections.
    J Antimicrob Chemother. 2021;76:1315-1322.
    PubMed     Abstract available


  40. MARIMUTHU K, Mo Y, Ling ML, Hernandez-Koutoucheva A, et al
    Household transmission of carbapenemase-producing Enterobacteriaceae: a prospective cohort study.
    J Antimicrob Chemother. 2021;76:1299-1302.
    PubMed     Abstract available


  41. CASTANEDA X, Garcia-De-la-Maria C, Gasch O, Pericas JM, et al
    Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocardit
    J Antimicrob Chemother. 2021 Apr 9. pii: 6219388. doi: 10.1093.
    PubMed     Abstract available


  42. MOSER S, Rehm S, Guertler N, Hinic V, et al
    Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection: a prospective cohort study of unbound plasma and individual MICs.
    J Antimicrob Chemother. 2021 Apr 8. pii: 6227026. doi: 10.1093.
    PubMed     Abstract available


  43. JIANG N, Wyres KL, Li J, Fessler AT, et al
    Evolution and genomic insight into methicillin-resistant Staphylococcus aureus ST9 in China.
    J Antimicrob Chemother. 2021 Apr 5. pii: 6210593. doi: 10.1093.
    PubMed     Abstract available


  44. CHEN YH, Lin SY, Lin YT, Tseng SP, et al
    Emergence of aac(6')-Ie-aph(2'')-Ia-positive enterococci with non-high-level gentamicin resistance mediated by IS1216V: adaptation to decreased aminoglycoside usage in Taiwan.
    J Antimicrob Chemother. 2021 Apr 2. pii: 6208785. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  45. BRUSAMARELLO C, Daley AJ, Zhu X, Landersdorfer C, et al
    How important are MIC determination methods when targeting vancomycin levels in patients with Staphylococcus aureus infections?
    J Antimicrob Chemother. 2021 Mar 18. pii: 6177478. doi: 10.1093.
    PubMed    


  46. FALCONE M, Tiseo G, Giordano C, Leonildi A, et al
    Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study.
    J Antimicrob Chemother. 2021;76:1078-1084.
    PubMed     Abstract available


  47. NURNBERG S, Claus H, Krone M, Vogel U, et al
    Cefotaxime resistance in invasive Haemophilus influenzae isolates in Germany 2016-19: prevalence, epidemiology and relevance of PBP3 substitutions.
    J Antimicrob Chemother. 2021;76:920-929.
    PubMed     Abstract available


  48. VERSCHUUREN TD, van Hout D, Arredondo-Alonso S, Fluit AC, et al
    Comparative genomics of ESBL-producing Escherichia coli (ESBL-Ec) reveals a similar distribution of the 10 most prevalent ESBL-Ec clones and ESBL genes among human community faecal and extra-intestinal infection isolates in the Netherlands (2014-17).
    J Antimicrob Chemother. 2021;76:901-908.
    PubMed     Abstract available


  49. CORTAZZO V, Giordano L, D'Inzeo T, Fiori B, et al
    EUCAST rapid antimicrobial susceptibility testing of blood cultures positive for Escherichia coli or Klebsiella pneumoniae: experience of three laboratories in Italy.
    J Antimicrob Chemother. 2021;76:1110-1112.
    PubMed    


  50. YAN J, Chen Y, Yang F, Ling X, et al
    High percentage of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone among isolates from a single hospital in Hangzhou, China.
    J Antimicrob Chemother. 2021;76:936-939.
    PubMed     Abstract available


  51. ZHENG Z, Ye L, Li R, Chen S, et al
    Whole-genome sequencing of strains of Vibrio spp. from China reveals different genetic contexts of blaCTX-M-14 among diverse lineages.
    J Antimicrob Chemother. 2021;76:950-956.
    PubMed     Abstract available


  52. SALMERON P, Moreno-Mingorance A, Trejo J, Amado R, et al
    Emergence and dissemination of three mild outbreaks of Neisseria gonorrhoeae with high-level resistance to azithromycin in Barcelona, 2016-18.
    J Antimicrob Chemother. 2021;76:930-935.
    PubMed     Abstract available


  53. AHMADI MH
    Resistance to tetracyclines among clinical isolates of Mycoplasma hominis and Ureaplasma species: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2021;76:865-875.
    PubMed     Abstract available


  54. DIEZ-AGUILAR M, Hernandez-Garcia M, Morosini MI, Fluit A, et al
    Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates.
    J Antimicrob Chemother. 2021;76:984-992.
    PubMed     Abstract available


  55. COLLINS DA, Wu Y, Tateda K, Kim HJ, et al
    Evaluation of the antimicrobial activity of ridinilazole and six comparators against Chinese, Japanese and South Korean strains of Clostridioides difficile.
    J Antimicrob Chemother. 2021;76:967-972.
    PubMed     Abstract available


  56. LIN EY, Adamson PC, Klausner JD
    Evaluating the generalizability of a multiplex real-time PCR assay for predicting decreased susceptibility to ceftriaxone in a global set of Neisseria gonorrhoeae sequences.
    J Antimicrob Chemother. 2021;76:1104-1106.
    PubMed    


  57. CABOT G, Lara-Esbri P, Mulet X, Oliver A, et al
    Whole-genome sequence-guided PCR for the rapid identification of the Pseudomonas aeruginosa ST175 high-risk clone directly from clinical samples.
    J Antimicrob Chemother. 2021;76:945-949.
    PubMed     Abstract available


  58. CHEW KL, Octavia S, Go J, Ng S, et al
    In vitro susceptibility of Mycobacterium abscessus complex and feasibility of standardizing treatment regimens.
    J Antimicrob Chemother. 2021;76:973-978.
    PubMed     Abstract available


  59. NUCCI M, Jenks J, Thompson GR, Hoenigl M, et al
    Do high MICs predict the outcome in invasive fusariosis?
    J Antimicrob Chemother. 2021;76:1063-1069.
    PubMed     Abstract available


  60. BENTZ ML, Nunnally N, Lockhart SR, Sexton DJ, et al
    Antifungal activity of nikkomycin Z against Candida auris.
    J Antimicrob Chemother. 2021 Mar 3. pii: 6157462. doi: 10.1093.
    PubMed     Abstract available


  61. SHANG Y, Lv P, Li S, Wang W, et al
    Allele-based analysis revealed the critical functions of region 277-297 in the NorA efflux pump of Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Mar 3. pii: 6157432. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  62. FERNANDEZ-HUERTA M, Serra-Pladevall J, Pumarola T, Pich OQ, et al
    Comment on: Lower mgpB diversity in macrolide-resistant Mycoplasma genitalium infecting men visiting two sexually transmitted infection clinics in Montpellier, France.
    J Antimicrob Chemother. 2021 Feb 28. pii: 6154381. doi: 10.1093.
    PubMed    


  63. PORTAL E, Descours G, Ginevra C, Mentasti M, et al
    Legionella antibiotic susceptibility testing: is it time for international standardization and evidence-based guidance?
    J Antimicrob Chemother. 2021 Feb 20. pii: 6145330. doi: 10.1093.
    PubMed     Abstract available


  64. RACHINA S, Zakharenkov I, Dekhnich N, Kozlov R, et al
    Aetiology of severe community-acquired pneumonia and antimicrobial susceptibility of Streptococcus pneumoniae in adults in Russia.
    J Antimicrob Chemother. 2021 Feb 19. pii: 6144791. doi: 10.1093.
    PubMed    


  65. BROWN NM, Brown EM
    Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK.
    J Antimicrob Chemother. 2021 Feb 14. pii: 6134889. doi: 10.1093.
    PubMed     Abstract available


  66. WANG L, Amin AK, Khanna P, Aali A, et al
    An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
    J Antimicrob Chemother. 2021;76:796-803.
    PubMed     Abstract available


  67. SALMERON P, Vinado B, Arando M, Alcoceba E, et al
    Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study.
    J Antimicrob Chemother. 2021 Feb 11. pii: 6132746. doi: 10.1093.
    PubMed     Abstract available


  68. TAKEBAYASHI Y, Findlay J, Heesom KJ, Warburton PJ, et al
    Variability in carbapenemase activity of intrinsic OxaAb (OXA-51-like) beta-lactamase enzymes in Acinetobacter baumannii.
    J Antimicrob Chemother. 2021;76:587-595.
    PubMed     Abstract available


  69. GUO S, Aung KT, Leekitcharoenphon P, Tay MYF, et al
    Prevalence and genomic analysis of ESBL-producing Escherichia coli in retail raw meats in Singapore.
    J Antimicrob Chemother. 2021;76:601-605.
    PubMed     Abstract available


  70. WOLTER DJ, Scott A, Armbruster CR, Whittington D, et al
    Repeated isolation of an antibiotic-dependent and temperature-sensitive mutant of Pseudomonas aeruginosa from a cystic fibrosis patient.
    J Antimicrob Chemother. 2021;76:616-625.
    PubMed     Abstract available


  71. KUO SC, Tan MC, Huang WC, Wu HC, et al
    Susceptibility of Elizabethkingia spp. to commonly tested and novel antibiotics and concordance between broth microdilution and automated testing methods.
    J Antimicrob Chemother. 2021;76:653-658.
    PubMed     Abstract available


  72. SPRUTE R, Salmanton-Garcia J, Sal E, Malaj X, et al
    Characterization and outcome of invasive infections due to Paecilomyces variotii: analysis of patients from the FungiScope(R) registry and literature reports.
    J Antimicrob Chemother. 2021;76:765-774.
    PubMed     Abstract available


  73. KARAISKOS I, Daikos GL, Gkoufa A, Adamis G, et al
    Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study.
    J Antimicrob Chemother. 2021;76:775-783.
    PubMed     Abstract available


  74. BALTAS I, Stockdale T, Tausan M, Kashif A, et al
    Impact of antibiotic timing on mortality from Gram-negative bacteraemia in an English district general hospital: the importance of getting it right every time.
    J Antimicrob Chemother. 2021;76:813-819.
    PubMed     Abstract available


  75. YAO H, Zhao W, Jiao D, Schwarz S, et al
    Global distribution, dissemination and overexpression of potent multidrug efflux pump RE-CmeABC in Campylobacter jejuni.
    J Antimicrob Chemother. 2021;76:596-600.
    PubMed     Abstract available


  76. TIETGEN M, Leukert L, Sommer J, Kramer JS, et al
    Characterization of the novel OXA-213-like beta-lactamase OXA-822 from Acinetobacter calcoaceticus.
    J Antimicrob Chemother. 2021;76:626-634.
    PubMed     Abstract available


  77. COLOMBO AL, Agnelli C, Kontoyiannis DP
    Knowledge gaps in candidaemia/invasive candidiasis in haematological cancer patients.
    J Antimicrob Chemother. 2021;76:543-546.
    PubMed     Abstract available


  78. FERNANDEZ-CUENCA F, Lopez-Hernandez I, Cercenado E, Conejo C, et al
    Reporting antimicrobial susceptibilities and resistance phenotypes in Staphylococcus spp.: a nationwide proficiency study.
    J Antimicrob Chemother. 2021 Feb 8. pii: 6130710. doi: 10.1093.
    PubMed     Abstract available


  79. LE ROY C, Touati A, Balcon C, Garraud J, et al
    Identification of 16S rRNA mutations in Mycoplasma genitalium potentially associated with tetracycline resistance in vivo but not selected in vitro in M. genitalium and Chlamydia trachomatis.
    J Antimicrob Chemother. 2021 Feb 4. pii: 6127604. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  80. GIANNELLA M, Bartoletti M, Conti M, Righi E, et al
    Carbapenemase-producing Enterobacteriaceae in transplant patients.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  81. TSIOUTIS C, Eichel VM, Mutters NT
    Transmission of Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: the role of infection control.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  82. CARRARA E, Conti M, Meschiari M, Mussini C, et al
    The role of antimicrobial stewardship in preventing KPC-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  83. KERNEIS S, Lucet JC, Santoro A, Meschiari M, et al
    Individual and collective impact of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in patients admitted to the ICU.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  84. PAUL M
    Management of KPC-producing Klebsiella pneumoniae in clinical practice: introduction.
    J Antimicrob Chemother. 2021;76.
    PubMed    


  85. GOMEZ-SIMMONDS A, Annavajhala MK, McConville TH, Dietz DE, et al
    Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital.
    J Antimicrob Chemother. 2021;76:380-384.
    PubMed     Abstract available


  86. MOSER AI, Kuenzli E, Budel T, Campos-Madueno EI, et al
    Travellers returning from the island of Zanzibar colonized with MDR Escherichia coli strains: assessing the impact of local people and other sources.
    J Antimicrob Chemother. 2021;76:330-337.
    PubMed     Abstract available


  87. CAMARA J, Grau I, Gonzalez-Diaz A, Tubau F, et al
    A historical perspective of MDR invasive pneumococcal disease in Spanish adults.
    J Antimicrob Chemother. 2021;76:507-515.
    PubMed     Abstract available


  88. MARI-ALMIRALL M, Cosgaya C, Pitart C, Vines J, et al
    Dissemination of NDM-producing Klebsiella pneumoniae and Escherichia coli high-risk clones in Catalan healthcare institutions.
    J Antimicrob Chemother. 2021;76:345-354.
    PubMed     Abstract available


  89. DI PILATO V, Errico G, Monaco M, Giani T, et al
    The changing epidemiology of carbapenemase-producing Klebsiella pneumoniae in Italy: toward polyclonal evolution with emergence of high-risk lineages.
    J Antimicrob Chemother. 2021;76:355-361.
    PubMed     Abstract available


  90. PAULY N, Hammerl JA, Schwarz S, Grobbel M, et al
    Co-occurrence of the blaVIM-1 and blaSHV-12 genes on an IncHI2 plasmid of an Escherichia coli isolate recovered from German livestock.
    J Antimicrob Chemother. 2021;76:531-533.
    PubMed    


  91. SILVA L, Grosso F, Rodrigues C, Ksiezarek M, et al
    The success of particular Acinetobacter baumannii clones: accumulating resistance and virulence inside a sugary shield.
    J Antimicrob Chemother. 2021;76:305-311.
    PubMed     Abstract available


  92. AULIN LBS, Koumans CIM, Haakman Y, van Os W, et al
    Distinct evolution of colistin resistance associated with experimental resistance evolution models in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021;76:533-535.
    PubMed    


  93. MAILLARD A, Scemla A, Laffy B, Mahloul N, et al
    Safety and efficacy of fumagillin for the treatment of intestinal microsporidiosis. A French prospective cohort study.
    J Antimicrob Chemother. 2021;76:487-494.
    PubMed     Abstract available


  94. LI LH, Yang YS, Sun JR, Huang TW, et al
    Clinical and molecular characterization of Acinetobacter seifertii in Taiwan.
    J Antimicrob Chemother. 2021;76:312-321.
    PubMed     Abstract available


  95. LEE YM, Moon C, Park KH
    Is short-term antibiotic therapy safe in patients with central venous catheter-related Gram-negative bacteraemia?
    J Antimicrob Chemother. 2021;76:539-541.
    PubMed    


  96. HERNANDEZ-GARCIA M, Garcia-Castillo M, Garcia-Fernandez S, Melo-Cristino J, et al
    Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS.
    J Antimicrob Chemother. 2021;76:370-379.
    PubMed     Abstract available


  97. AIHARA M, Nishida R, Akimoto M, Gotoh Y, et al
    Within-host evolution of a Klebsiella pneumoniae clone: selected mutations associated with the alteration of outer membrane protein expression conferred multidrug resistance.
    J Antimicrob Chemother. 2021;76:362-369.
    PubMed     Abstract available


  98. HAMIDIAN M, Ambrose SJ, Blackwell GA, Nigro SJ, et al
    An outbreak of multiply antibiotic-resistant ST49:ST128:KL11:OCL8 Acinetobacter baumannii isolates at a Sydney hospital.
    J Antimicrob Chemother. 2021 Jan 16. pii: 6102239. doi: 10.1093.
    PubMed     Abstract available


  99. SWEENEY EL, Lowry K, Bletchly C, Nimmo GR, et al
    Mycoplasma genitalium infections can comprise a mixture of both fluoroquinolone-susceptible and fluoroquinolone-resistant strains.
    J Antimicrob Chemother. 2021 Jan 15. pii: 6100778. doi: 10.1093.
    PubMed     Abstract available


  100. ZHU Y, Zhang W, Liu S, Schwarz S, et al
    Identification of an IS431-derived translocatable unit containing the erm(C) gene in Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jan 11. pii: 6082781. doi: 10.1093.
    PubMed    


  101. GOLPARIAN D, Sanchez-Buso L, Cole M, Unemo M, et al
    Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance (NG-STAR) clonal complexes are consistent with genomic phylogeny and provide simple nomenclature, rapid visualization and antimicrobial resistance (AMR) lineage predictions.
    J Antimicrob Chemother. 2021 Jan 7. pii: 6067623. doi: 10.1093.
    PubMed     Abstract available


  102. BUDIN S, Salmanton-Garcia J, Koehler P, Stemler J, et al
    Validation of the EQUAL Aspergillosis Score by analysing guideline-adherent management of invasive pulmonary aspergillosis.
    J Antimicrob Chemother. 2021 Jan 4. pii: 6062083. doi: 10.1093.
    PubMed     Abstract available


  103. OUESLATI S, Volland H, Cattoir V, Bernabeu S, et al
    Development and validation of a lateral flow immunoassay for rapid detection of VanA-producing enterococci.
    J Antimicrob Chemother. 2021;76:146-151.
    PubMed     Abstract available


  104. BEZABIH YM, Sabiiti W, Alamneh E, Bezabih A, et al
    The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community.
    J Antimicrob Chemother. 2021;76:22-29.
    PubMed     Abstract available


  105. ARCA-SUAREZ J, Lasarte-Monterrubio C, Rodino-Janeiro BK, Cabot G, et al
    Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections.
    J Antimicrob Chemother. 2021;76:91-100.
    PubMed     Abstract available


  106. DUGGETT N, Ellington MJ, Hopkins KL, Ellaby N, et al
    Detection in livestock of the human pandemic Escherichia coli ST131 fimH30(R) clone carrying blaCTX-M-27.
    J Antimicrob Chemother. 2021;76:263-265.
    PubMed    


  107. KHANINA A, Urbancic KF, Haeusler GM, Kong DCM, et al
    Establishing essential metrics for antifungal stewardship in hospitals: the results of an international Delphi survey.
    J Antimicrob Chemother. 2021;76:253-262.
    PubMed     Abstract available


  108. PEREZ-VISO B, Hernandez-Garcia M, Ponce-Alonso M, Morosini MI, et al
    Characterization of carbapenemase-producing Serratia marcescens and whole-genome sequencing for plasmid typing in a hospital in Madrid, Spain (2016-18).
    J Antimicrob Chemother. 2021;76:110-116.
    PubMed     Abstract available


  109. TREMBIZKI E, Jennison AV, Buckley C, Bright A, et al
    Enhanced molecular surveillance in response to the detection of extensively resistant gonorrhoea in Australia.
    J Antimicrob Chemother. 2021;76:270-271.
    PubMed    


  110. LOUKA C, Ravensbergen SJ, Ott A, Zhou X, et al
    Predominance of CTX-M-15-producing ST131 strains among ESBL-producing Escherichia coli isolated from asylum seekers in the Netherlands.
    J Antimicrob Chemother. 2021;76:70-76.
    PubMed     Abstract available


  111. BOEL JB, Antsupova V, Knudsen JD, Jarlov JO, et al
    Intravenous mecillinam compared with other beta-lactams as targeted treatment for Escherichia coli or Klebsiella spp. bacteraemia with urinary tract focus.
    J Antimicrob Chemother. 2021;76:206-211.
    PubMed     Abstract available


  112. TANG Y, Lai Y, Kong L, Wang X, et al
    Characterization of three porcine Escherichia coli isolates co-harbouring tet(X4) and cfr.
    J Antimicrob Chemother. 2021;76:263-264.
    PubMed    


  113. KUMWENDA GP, Sugawara Y, Akeda Y, Matsumoto Y, et al
    Genomic features of plasmids coding for KPC-2, NDM-5 or OXA-48 carbapenemases in Enterobacteriaceae from Malawi.
    J Antimicrob Chemother. 2021;76:267-270.
    PubMed    


  114. ABBOTSFORD J, Foley DA, Goff Z, Bowen AC, et al
    Clinical experience with SUBA-itraconazole at a tertiary paediatric hospital.
    J Antimicrob Chemother. 2021;76:249-252.
    PubMed     Abstract available


  115. BUCKLEY AM, Altringham J, Clark E, Bently K, et al
    Eravacycline, a novel tetracycline derivative, does not induce Clostridioides difficile infection in an in vitro human gut model.
    J Antimicrob Chemother. 2021;76:171-178.
    PubMed     Abstract available


    December 2020
  116. ALGHAMDI WA, Al-Shaer MH, Kipiani M, Barbakadze K, et al
    Pharmacokinetics of bedaquiline, delamanid and clofazimine in patients with multidrug-resistant tuberculosis.
    J Antimicrob Chemother. 2020 Dec 30. pii: 6055881. doi: 10.1093.
    PubMed     Abstract available


  117. CRUCIANI M, White PL, Mengoli C, Loffler J, et al
    The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis.
    J Antimicrob Chemother. 2020 Dec 29. pii: 6055077. doi: 10.1093.
    PubMed     Abstract available


  118. WEINER M, Gelfond J, Johnson-Pais TL, Engle M, et al
    Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis.
    J Antimicrob Chemother. 2020 Dec 29. pii: 6055076. doi: 10.1093.
    PubMed     Abstract available


  119. XANTHOPOULOU K, Wille J, Zweigner J, Lucassen K, et al
    Characterization of a vancomycin-resistant Enterococcus faecium isolate and a vancomycin-susceptible E. faecium isolate from the same blood culture.
    J Antimicrob Chemother. 2020 Dec 28. pii: 6054276. doi: 10.1093.
    PubMed     Abstract available


  120. WAGNER TM, Janice J, Sivertsen A, Sjogren I, et al
    Alternative vanHAX promoters and increased vanA-plasmid copy number resurrect silenced glycopeptide resistance in Enterococcus faecium.
    J Antimicrob Chemother. 2020 Dec 26. pii: 6050581. doi: 10.1093.
    PubMed     Abstract available


  121. BLACKMAN A, Morrison B, Maruri F, van der Heijden Y, et al
    Re-evaluation of a novel resistance mutation in eccC5 of the ESX-5 secretion system in ofloxacin-resistant Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2020 Dec 23. pii: 6046147. doi: 10.1093.
    PubMed    


  122. LARRAMENDY S, Gaultier A, Fournier JP, Caillon J, et al
    Local characteristics associated with higher prevalence of ESBL-producing Escherichia coli in community-acquired urinary tract infections: an observational, cross-sectional study.
    J Antimicrob Chemother. 2020 Dec 22. pii: 6042378. doi: 10.1093.
    PubMed     Abstract available


  123. TAHSEEN S, vanDeun A, de Jong BC, Decroo T, et al
    Second-line injectable drugs for rifampicin-resistant tuberculosis: better the devil we know?
    J Antimicrob Chemother. 2020 Dec 1. pii: 6015577. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  124. ZHU Y, Wang C, Schwarz S, Liu W, et al
    Identification of a novel tetracycline resistance gene, tet(63), located on a multiresistance plasmid from Staphylococcus aureus.
    J Antimicrob Chemother. 2020 Nov 28. pii: 6008797. doi: 10.1093.
    PubMed     Abstract available


  125. ARASTEHFAR A, Daneshnia F, Hilmioglu-Polat S, Ilkit M, et al
    Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?
    J Antimicrob Chemother. 2020 Nov 11. pii: 5974114. doi: 10.1093.
    PubMed     Abstract available


  126. SHROPSHIRE WC, Aitken SL, Pifer R, Kim J, et al
    IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort.
    J Antimicrob Chemother. 2020 Nov 9. pii: 5961599. doi: 10.1093.
    PubMed     Abstract available


  127. HAYAJNEH WA, Al-Azzam S, Yusef D, Lattyak WJ, et al
    Identification of thresholds in relationships between specific antibiotic use and carbapenem-resistant Acinetobacter baumannii (CRAb) incidence rates in hospitalized patients in Jordan.
    J Antimicrob Chemother. 2020 Nov 5. pii: 5957247. doi: 10.1093.
    PubMed     Abstract available


  128. MIZUSHIMA D, Takano M, Uemura H, Yanagawa Y, et al
    Effectiveness of doxycycline 100 mg twice daily for 7 days and azithromycin 1 g single dose for the treatment of rectal Chlamydia trachomatis infection among men who have sex with men.
    J Antimicrob Chemother. 2020 Nov 4. pii: 5955928. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  129. TKADLEC J, Capek V, Brajerova M, Smelikova E, et al
    The molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in the Czech Republic.
    J Antimicrob Chemother. 2020 Oct 29. pii: 5942696. doi: 10.1093.
    PubMed     Abstract available


  130. GUIRAUD J, Lounnas M, Boissiere A, Le Roy C, et al
    Lower mgpB diversity in macrolide-resistant Mycoplasma genitalium infecting men visiting two sexually transmitted infection clinics in Montpellier, France.
    J Antimicrob Chemother. 2020 Oct 20. pii: 5930856. doi: 10.1093.
    PubMed     Abstract available


  131. YANG Q, Li X, Jia P, Giske C, et al
    Determination of norvancomycin epidemiological cut-off values (ECOFFs) for Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus hominis.
    J Antimicrob Chemother. 2020 Oct 14. pii: 5923762. doi: 10.1093.
    PubMed     Abstract available


  132. ARA-MONTOJO MF, Escosa-Garcia L, Alguacil-Guillen M, Seara N, et al
    Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children.
    J Antimicrob Chemother. 2020 Oct 10. pii: 5920733. doi: 10.1093.
    PubMed     Abstract available


  133. PAPATHANAKOS G, Andrianopoulos I, Papathanasiou A, Koulenti D, et al
    Pandrug-resistant Acinetobacter baumannii treatment: still a debatable topic with no definite solutions.
    J Antimicrob Chemother. 2020;75:3081.
    PubMed    


    September 2020
  134. HADAD R, Cole MJ, Ebeyan S, Jacobsson S, et al
    Evaluation of the SpeeDx ResistancePlus(R) GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905664. doi: 10.1093.
    PubMed     Abstract available


  135. ROUX J, Nekkab N, Colomb-Cotinat M, Astagneau P, et al
    Time-series modelling for the quantification of seasonality and forecasting antibiotic-resistant episodes: application to carbapenemase-producing Enterobacteriaceae episodes in France over 2010-20.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905635. doi: 10.1093.
    PubMed     Abstract available


  136. AMBROSE SJ, Hall RM
    A novel trimethoprim resistance gene, dfrA38, found in a sporadic Acinetobacter baumannii isolate.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905668. doi: 10.1093.
    PubMed    


    August 2020
  137. NOVAK-FRAZER L, Anees-Hill SP, Hassan D, Masania R, et al
    Deciphering Aspergillus fumigatus cyp51A-mediated triazole resistance by pyrosequencing of respiratory specimens.
    J Antimicrob Chemother. 2020 Aug 30. pii: 5899263. doi: 10.1093.
    PubMed     Abstract available


  138. RICHELSEN R, Smit J, Schonheyder HC, Laxsen Anru P, et al
    Outcome of community-onset ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and urinary tract infection: a population-based cohort study in Denmark.
    J Antimicrob Chemother. 2020 Aug 30. pii: 5899248. doi: 10.1093.
    PubMed     Abstract available


  139. DIACONU EL, Carfora V, Alba P, Di Matteo P, et al
    Novel IncFII plasmid harbouring blaNDM-4 in a carbapenem-resistant Escherichia coli of pig origin, Italy.
    J Antimicrob Chemother. 2020 Aug 24. pii: 5896583. doi: 10.1093.
    PubMed     Abstract available


  140. SIOPI M, Rivero-Menendez O, Gkotsis G, Panara A, et al
    Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece: detection of pan-azole resistance associated with the TR46/Y121F/T289A cyp51A mutation.
    J Antimicrob Chemother. 2020 Aug 20. pii: 5894665. doi: 10.1093.
    PubMed     Abstract available


  141. MAITRA A, Evangelopoulos D, Chrzastek A, Martin LT, et al
    Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis.
    J Antimicrob Chemother. 2020 Aug 13. pii: 5892302. doi: 10.1093.
    PubMed     Abstract available


  142. JACOBS TG, Svensson EM, Musiime V, Rojo P, et al
    Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review.
    J Antimicrob Chemother. 2020 Aug 12. pii: 5891804. doi: 10.1093.
    PubMed     Abstract available


  143. LYU T, Cheung KS, Ni L, Guo J, et al
    High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort study.
    J Antimicrob Chemother. 2020 Aug 12. pii: 5891805. doi: 10.1093.
    PubMed     Abstract available


  144. GOLPARIAN D, Bazzo ML, Golfetto L, Gaspar PC, et al
    Genomic epidemiology of Neisseria gonorrhoeae elucidating the gonococcal antimicrobial resistance and lineages/sublineages across Brazil, 2015-16.
    J Antimicrob Chemother. 2020 Aug 12. pii: 5891806. doi: 10.1093.
    PubMed     Abstract available


  145. SHAN X, Li XS, Wang N, Schwarz S, et al
    Studies on the role of IS1216E in the formation and dissemination of poxtA-carrying plasmids in an Enterococcus faecium clade A1 isolate.
    J Antimicrob Chemother. 2020 Aug 8. pii: 5890036. doi: 10.1093.
    PubMed     Abstract available


    July 2020
  146. HORNER C, Mushtaq S, Livermore DM
    Activity of ceftaroline versus ceftobiprole against staphylococci and pneumococci in the UK and Ireland: analysis of BSAC surveillance data.
    J Antimicrob Chemother. 2020 Jul 29. pii: 5878179. doi: 10.1093.
    PubMed     Abstract available


  147. ZHU Y, Zhang W, Wang C, Liu W, et al
    Identification of a novel optrA-harbouring transposon, Tn6823, in Staphylococcus aureus.
    J Antimicrob Chemother. 2020 Jul 29. pii: 5878177. doi: 10.1093.
    PubMed    


  148. DAI VTT, Beissbarth J, Thanh PV, Hoan PT, et al
    Hospital surveillance predicts community pneumococcal antibiotic resistance in Vietnam.
    J Antimicrob Chemother. 2020 Jul 29. pii: 5878176. doi: 10.1093.
    PubMed     Abstract available


  149. WARN P, Thommes P, Sharp A, Sattar A, et al
    Intermittent micafungin for prophylaxis in a rat model of chronic Candida albicans gut colonization.
    J Antimicrob Chemother. 2020 Jul 28. pii: 5877001. doi: 10.1093.
    PubMed     Abstract available


  150. XANTHOPOULOU K, Peter S, Tobys D, Behnke M, et al
    Vancomycin-resistant Enterococcus faecium colonizing patients on hospital admission in Germany: prevalence and molecular epidemiology.
    J Antimicrob Chemother. 2020 Jul 22. pii: 5875232. doi: 10.1093.
    PubMed     Abstract available


  151. LI Y, Xiu L, Liu J, Zhang C, et al
    A multiplex assay for characterization of antimicrobial resistance in Neisseria gonorrhoeae using multi-PCR coupled with mass spectrometry.
    J Antimicrob Chemother. 2020 Jul 20. pii: 5874078. doi: 10.1093.
    PubMed     Abstract available


  152. CHAN AP, Choi Y, Clarke TH, Brinkac LM, et al
    AbGRI4, a novel antibiotic resistance island in multiply antibiotic-resistant Acinetobacter baumannii clinical isolates.
    J Antimicrob Chemother. 2020 Jul 18. pii: 5873331. doi: 10.1093.
    PubMed     Abstract available


  153. ZHANG S, Wang X, Wise MJ, He Y, et al
    Mutations of Helicobacter pylori RdxA are mainly related to the phylogenetic origin of the strain and not to metronidazole resistance.
    J Antimicrob Chemother. 2020 Jul 17. pii: 5872801. doi: 10.1093.
    PubMed     Abstract available


  154. RIVAYA B, Jordana-Lluch E, Fernandez-Rivas G, Molinos S, et al
    Macrolide resistance and molecular typing of Mycoplasma pneumoniae infections during a 4 year period in Spain.
    J Antimicrob Chemother. 2020 Jul 12. pii: 5870410. doi: 10.1093.
    PubMed     Abstract available


  155. CAO T, Liu Y, Li Y, Wang Y, et al
    A public health concern: emergence of carbapenem-resistant Klebsiella pneumoniae in a public transportation environment.
    J Antimicrob Chemother. 2020 Jul 4. pii: 5867249. doi: 10.1093.
    PubMed     Abstract available


  156. FREITAS AR, Tedim AP, Duarte B, Elghaieb H, et al
    Linezolid-resistant (Tn6246::fexB-poxtA) Enterococcus faecium strains colonizing humans and bovines on different continents: similarity without epidemiological link.
    J Antimicrob Chemother. 2020 Jul 1. pii: 5865502. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  157. RAMBAUD A, Gaborit BJ, Deschanvres C, Le Turnier P, et al
    Development and validation of a dosing nomogram for amoxicillin in infective endocarditis.
    J Antimicrob Chemother. 2020 Jun 30. pii: 5864955. doi: 10.1093.
    PubMed     Abstract available


  158. SATO T, Wada T, Shinagawa M, Fukushima Y, et al
    Emergence of vancomycin- and teicoplanin-resistant Enterococcus faecium via vanD5-harbouring large genomic island.
    J Antimicrob Chemother. 2020 Jun 25. pii: 5862743. doi: 10.1093.
    PubMed     Abstract available


  159. SARAVOLATZ LD, Pawlak JM, Wegner C
    Delafloxacin activity against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
    J Antimicrob Chemother. 2020 Jun 15. pii: 5857662. doi: 10.1093.
    PubMed     Abstract available


  160. BUIL JB, Bruggemann RJM, Bedin Denardi L, Melchers WJG, et al
    In vitro interaction of isavuconazole and anidulafungin against azole-susceptible and azole-resistant Aspergillus fumigatus isolates.
    J Antimicrob Chemother. 2020 Jun 9. pii: 5855124. doi: 10.1093.
    PubMed     Abstract available


  161. SEIFERT H, Muller C, Stefanik D, Higgins PG, et al
    In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii.
    J Antimicrob Chemother. 2020 Jun 9. pii: 5855123. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  162. YANG M, Li XS, Li D, Shang Y, et al
    Two novel lsa(E)-carrying mobile genetic elements in Streptococcus suis.
    J Antimicrob Chemother. 2020 May 28. pii: 5848381. doi: 10.1093.
    PubMed    


  163. DEJOIES L, Boukthir S, Pean de Ponfilly G, Le Guen R, et al
    Performance of commercial methods for linezolid susceptibility testing of Enterococcus faecium and Enterococcus faecalis.
    J Antimicrob Chemother. 2020 May 25. pii: 5843866. doi: 10.1093.
    PubMed     Abstract available


  164. LAM TT, Nurnberg S, Claus H, Vogel U, et al
    Molecular epidemiology of imipenem resistance in invasive Haemophilus influenzae infections in Germany in 2016.
    J Antimicrob Chemother. 2020 May 25. pii: 5843865. doi: 10.1093.
    PubMed     Abstract available


  165. STEWART AG, Harris PNA, Henderson A, Schembri MA, et al
    Oral cephalosporin and beta-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections.
    J Antimicrob Chemother. 2020 May 22. pii: 5842233. doi: 10.1093.
    PubMed     Abstract available


  166. PAGANO P, Marra A, Shinabarger D, Pillar C, et al
    In vitro activity of omadacycline and levofloxacin against Escherichia coli, Klebsiella pneumoniae and Staphylococcus saprophyticus in human urine supplemented with calcium and magnesium.
    J Antimicrob Chemother. 2020 May 19. pii: 5840661. doi: 10.1093.
    PubMed     Abstract available


  167. DE LASTOURS V, Laouenan C, Royer G, Carbonnelle E, et al
    Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.
    J Antimicrob Chemother. 2020 May 17. pii: 5838343. doi: 10.1093.
    PubMed     Abstract available


  168. MARTINEZ EP, van Rosmalen J, Bustillos R, Natsch S, et al
    Trends, seasonality and the association between outpatient antibiotic use and antimicrobial resistance among urinary bacteria in the Netherlands.
    J Antimicrob Chemother. 2020 May 17. pii: 5838345. doi: 10.1093.
    PubMed     Abstract available


  169. EICHEL V, Klein S, Bootsveld C, Frank U, et al
    Challenges in interpretation of WGS and epidemiological data to investigate nosocomial transmission of vancomycin-resistant Enterococcus faecium in an endemic region: incorporation of patient movement network and admission screening.
    J Antimicrob Chemother. 2020 May 15. pii: 5837672. doi: 10.1093.
    PubMed     Abstract available


  170. CHANAME PINEDO LE, Bruyndonckx R, Catry B, Latour K, et al
    Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: a retrospective case-control study.
    J Antimicrob Chemother. 2020 May 12. pii: 5836063. doi: 10.1093.
    PubMed     Abstract available


  171. MANOHARAN A, Das T, Whiteley GS, Glasbey T, et al
    The effect of N-acetylcysteine in a combined antibiofilm treatment against antibiotic-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2020 May 3. pii: 5828489. doi: 10.1093.
    PubMed     Abstract available


  172. KADURA S, King N, Nakhoul M, Zhu H, et al
    Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid.
    J Antimicrob Chemother. 2020 May 3. pii: 5828363. doi: 10.1093.
    PubMed     Abstract available


  173. BAKTHAVATCHALAM YD, Shankar A, Muniyasamy R, Peter JV, et al
    Levonadifloxacin, a recently approved benzoquinolizine fluoroquinolone, exhibits potent in vitro activity against contemporary Staphylococcus aureus isolates and Bengal Bay clone isolates collected from a large Indian tertiary care hospital.
    J Antimicrob Chemother. 2020 May 3. pii: 5828350. doi: 10.1093.
    PubMed     Abstract available


  174. ABBOTT IJ, van Gorp E, Wijma RA, Dekker J, et al
    Efficacy of single and multiple oral doses of fosfomycin against Pseudomonas aeruginosa urinary tract infections in a dynamic in vitro bladder infection model.
    J Antimicrob Chemother. 2020 May 3. pii: 5828355. doi: 10.1093.
    PubMed     Abstract available


  175. THIEME L, Hartung A, Makarewicz O, Pletz MW, et al
    In vivo synergism of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis assessed in the Galleria mellonella infection model.
    J Antimicrob Chemother. 2020 May 1. pii: 5827806. doi: 10.1093.
    PubMed     Abstract available


  176. RIEG S, Ernst A, Peyerl-Hoffmann G, Joost I, et al
    Combination therapy with rifampicin or fosfomycin in patients with Staphylococcus aureus bloodstream infection at high risk for complications or relapse: results of a large prospective observational cohort.
    J Antimicrob Chemother. 2020 May 1. pii: 5827555. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  177. MELETIADIS J, Siopi M, Kanioura L, Jorgensen KM, et al
    A multicentre study to optimize echinocandin susceptibility testing of Aspergillus species with the EUCAST methodology and a broth microdilution colorimetric method.
    J Antimicrob Chemother. 2020 Apr 24. pii: 5824917. doi: 10.1093.
    PubMed     Abstract available


  178. YOSHIDA S, Iwamoto T, Arikawa K, Sekizuka T, et al
    Bacterial population kinetics in heteroresistant Mycobacterium tuberculosis harbouring rare resistance-conferring mutations in gyrA and rpoB imply an epistatic interaction of mutations in a pre-XDR-TB patient.
    J Antimicrob Chemother. 2020 Apr 17. pii: 5821489. doi: 10.1093.
    PubMed     Abstract available


  179. GUERIN F, Sassi M, Dejoies L, Zouari A, et al
    Molecular and functional analysis of the novel cfr(D) linezolid resistance gene identified in Enterococcus faecium.
    J Antimicrob Chemother. 2020 Apr 11. pii: 5819175. doi: 10.1093.
    PubMed     Abstract available


  180. BROWN E, Gould FK
    Oral antibiotics for infective endocarditis: a clinical review.
    J Antimicrob Chemother. 2020 Apr 2. pii: 5815249. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  181. ROHDE AM, Zweigner J, Wiese-Posselt M, Schwab F, et al
    Prevalence of third-generation cephalosporin-resistant Enterobacterales colonization on hospital admission and ESBL genotype-specific risk factors: a cross-sectional study in six German university hospitals.
    J Antimicrob Chemother. 2020 Mar 16. pii: 5805542. doi: 10.1093.
    PubMed     Abstract available


  182. CAMPBELL AJ, Daley DA, Bell JM, Pang S, et al
    Progress towards a coordinated, national paediatric antimicrobial resistance surveillance programme: Staphylococcus aureus, enterococcal and Gram-negative bacteraemia in Australia.
    J Antimicrob Chemother. 2020 Mar 10. pii: 5802603. doi: 10.1093.
    PubMed     Abstract available


  183. EGAN SA, Shore AC, O'Connell B, Brennan GI, et al
    Linezolid resistance in Enterococcus faecium and Enterococcus faecalis from hospitalized patients in Ireland: high prevalence of the MDR genes optrA and poxtA in isolates with diverse genetic backgrounds.
    J Antimicrob Chemother. 2020 Mar 4. pii: 5780432. doi: 10.1093.
    PubMed     Abstract available


  184. ABAD L, Josse J, Tasse J, Lustig S, et al
    Antibiofilm and intraosteoblastic activities of rifamycins against Staphylococcus aureus: promising in vitro profile of rifabutin.
    J Antimicrob Chemother. 2020 Mar 3. pii: 5775582. doi: 10.1093.
    PubMed     Abstract available


  185. RUBIN IMC, Pedersen MS, Mollerup S, Kaya H, et al
    Association between vancomycin-resistant Enterococcus faecium colonization and subsequent infection: a retrospective WGS study.
    J Antimicrob Chemother. 2020 Mar 3. pii: 5775585. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  186. GROWCOTT EJ, Gamboa L, Roth T, Lopez S, et al
    Efficacy of piperacillin in combination with novel beta-lactamase inhibitor IID572 against beta-lactamase-producing strains of Enterobacteriaceae and Staphylococcus aureus in murine neutropenic thigh infection models.
    J Antimicrob Chemother. 2020 Feb 28. pii: 5766087. doi: 10.1093.
    PubMed     Abstract available


  187. NICOLAS R, Carricajo A, Morel J, Rigaill J, et al
    Evaluation of effectiveness and compliance with the mupirocin nasal ointment part of Staphylococcus aureus decolonization in real life using UPLC-MS/MS mupirocin quantification.
    J Antimicrob Chemother. 2020 Feb 25. pii: 5757992. doi: 10.1093.
    PubMed     Abstract available


  188. HUANG J, Wang M, Gao Y, Chen L, et al
    Erratum to: Emergence of plasmid-mediated oxazolidinone resistance gene poxtA from CC17 Enterococcus faecium of pig origin.
    J Antimicrob Chemother. 2020 Feb 25. pii: 5757995. doi: 10.1093.
    PubMed    


  189. HUANG J, Wang M, Gao Y, Chen L, et al
    Emergence of plasmid-mediated oxazolidinone resistance gene poxtA from CC17 Enterococcus faecium of pig origin-authors' response.
    J Antimicrob Chemother. 2020 Feb 25. pii: 5757983. doi: 10.1093.
    PubMed    


  190. EISENBERGER D, Tuschak C, Werner M, Bogdan C, et al
    Whole-genome analysis of vancomycin-resistant Enterococcus faecium causing nosocomial outbreaks suggests the occurrence of few endemic clonal lineages in Bavaria, Germany.
    J Antimicrob Chemother. 2020 Feb 21. pii: 5743460. doi: 10.1093.
    PubMed     Abstract available


  191. LAN PT, Golparian D, Ringlander J, Van Hung L, et al
    Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015-16.
    J Antimicrob Chemother. 2020 Feb 18. pii: 5740025. doi: 10.1093.
    PubMed     Abstract available


  192. BOURELY C, Coeffic T, Caillon J, Thibaut S, et al
    Trends in antimicrobial resistance among Escherichia coli from defined infections in humans and animals.
    J Antimicrob Chemother. 2020 Feb 12. pii: 5734707. doi: 10.1093.
    PubMed     Abstract available


  193. KUEHL R, Morata L, Meylan S, Mensa J, et al
    When antibiotics fail: a clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureus.
    J Antimicrob Chemother. 2020 Feb 4. pii: 5722234. doi: 10.1093.
    PubMed     Abstract available


  194. HAGSTRAND ALDMAN M, Pahlman LI
    Evaluation of penicillin G susceptibility testing methods for Staphylococcus lugdunensis.
    J Antimicrob Chemother. 2020 Feb 4. pii: 5722233. doi: 10.1093.
    PubMed     Abstract available


  195. VAN RIE A, Whitfield MG, De Vos E, Scott L, et al
    Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact.
    J Antimicrob Chemother. 2020 Feb 4. pii: 5722231. doi: 10.1093.
    PubMed     Abstract available


  196. CEBALLOS GARZON A, Amado D, Robert E, Parra Giraldo CM, et al
    Impact of calmodulin inhibition by fluphenazine on susceptibility, biofilm formation and pathogenicity of caspofungin-resistant Candida glabrata.
    J Antimicrob Chemother. 2020 Feb 3. pii: 5721438. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  197. ALVAREZ-VEGA M, Boga JA, Fernandez-Suarez J, Martinez-Sela M, et al
    Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments-authors' response.
    J Antimicrob Chemother. 2020 Jan 16. pii: 5707452. doi: 10.1093.
    PubMed    


  198. PAINSET A, Day M, Doumith M, Rigby J, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Campylobacter jejuni and Campylobacter coli isolated from cases of diarrhoeal disease in England and Wales, 2015-16.
    J Antimicrob Chemother. 2020 Jan 16. pii: 5707358. doi: 10.1093.
    PubMed     Abstract available


  199. BROTHERTON AL, Rab S, Kandiah S, Kriengkauykiat J, et al
    The impact of an automated antibiotic stewardship intervention for the management of Staphylococcus aureus bacteraemia utilizing the electronic health record.
    J Antimicrob Chemother. 2020 Jan 13. pii: 5702184. doi: 10.1093.
    PubMed     Abstract available


  200. SITTERLE E, Coste AT, Obadia T, Maufrais C, et al
    Large-scale genome mining allows identification of neutral polymorphisms and novel resistance mutations in genes involved in Candida albicans resistance to azoles and echinocandins.
    J Antimicrob Chemother. 2020 Jan 10. pii: 5700447. doi: 10.1093.
    PubMed     Abstract available


  201. XIU L, Zhang C, Li Y, Wang F, et al
    High-resolution melting analysis for rapid detection of the internationally spreading ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone.
    J Antimicrob Chemother. 2020;75:106-109.
    PubMed     Abstract available


  202. SOREN O, Rineh A, Silva DG, Cai Y, et al
    Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2020;75:117-125.
    PubMed     Abstract available


  203. KIDD JM, Abdelraouf K, Nicolau DP
    Efficacy of human-simulated bronchopulmonary exposures of cefepime, zidebactam and the combination (WCK 5222) against MDR Pseudomonas aeruginosa in a neutropenic murine pneumonia model.
    J Antimicrob Chemother. 2020;75:149-155.
    PubMed     Abstract available


  204. PAUL D, Babenko D, Toleman MA
    Human carriage of cefotaxime-resistant Escherichia coli in North-East India: an analysis of STs and associated resistance mechanisms.
    J Antimicrob Chemother. 2020;75:72-76.
    PubMed     Abstract available


  205. WAREHAM DW, Momin MHFA, Phee LM, Hornsey M, et al
    Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.
    J Antimicrob Chemother. 2020;75:135-139.
    PubMed     Abstract available


  206. KIM J, Nakwa FL, Araujo Motta F, Liu H, et al
    A randomized, double-blind trial investigating the efficacy of caspofungin versus amphotericin B deoxycholate in the treatment of invasive candidiasis in neonates and infants younger than 3 months of age.
    J Antimicrob Chemother. 2020;75:215-220.
    PubMed     Abstract available


  207. MARTINEZ-GUITIAN M, Vazquez-Ucha JC, Alvarez-Fraga L, Conde-Perez K, et al
    Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by peptide-PNA conjugates and synergy with colistin.
    J Antimicrob Chemother. 2020;75:51-59.
    PubMed     Abstract available


  208. LUO Q, Wan F, Yu X, Zheng B, et al
    MDR Salmonella enterica serovar Typhimurium ST34 carrying mcr-1 isolated from cases of bloodstream and intestinal infection in children in China.
    J Antimicrob Chemother. 2020;75:92-95.
    PubMed     Abstract available


  209. SCHNEEWEISS S, Carver PL, Datta K, Galar A, et al
    Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals.
    J Antimicrob Chemother. 2020;75:221-228.
    PubMed     Abstract available


  210. MARTINS-SORENSON N, Snesrud E, Xavier DE, Cacci LC, et al
    A novel plasmid-encoded mcr-4.3 gene in a colistin-resistant Acinetobacter baumannii clinical strain.
    J Antimicrob Chemother. 2020;75:60-64.
    PubMed     Abstract available


  211. FINDLAY J, Gould VC, North P, Bowker KE, et al
    Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017-18.
    J Antimicrob Chemother. 2020;75:65-71.
    PubMed     Abstract available


    December 2019
  212. PARENT-MICHAUD M, Dufresne PJ, Fournier E, Folch B, et al
    Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 2013.
    J Antimicrob Chemother. 2019 Dec 31. pii: 5692254. doi: 10.1093.
    PubMed     Abstract available


  213. RUTH MM, Koeken VACM, Pennings LJ, Svensson EM, et al
    Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
    J Antimicrob Chemother. 2019 Dec 30. pii: 5690335. doi: 10.1093.
    PubMed     Abstract available


  214. ABBOTT IJ, Dekker J, van Gorp E, Wijma RA, et al
    Impact of bacterial species and baseline resistance on fosfomycin efficacy in urinary tract infections.
    J Antimicrob Chemother. 2019 Dec 24. pii: 5686404. doi: 10.1093.
    PubMed     Abstract available


  215. ALAM F, Catlow D, Di Maio A, Blair JMA, et al
    Candida albicans enhances meropenem tolerance of Pseudomonas aeruginosa in a dual-species biofilm.
    J Antimicrob Chemother. 2019 Dec 22. pii: 5684825. doi: 10.1093.
    PubMed     Abstract available


  216. WEGENER A, Damborg P, Guardabassi L, Moodley A, et al
    Specific staphylococcal cassette chromosome mec (SCCmec) types and clonal complexes are associated with low-level amoxicillin/clavulanic acid and cefalotin resistance in methicillin-resistant Staphylococcus pseudintermedius.
    J Antimicrob Chemother. 2019 Dec 17. pii: 5679833. doi: 10.1093.
    PubMed     Abstract available


  217. LO SW, Gladstone RA, van Tonder AJ, Du Plessis M, et al
    A mosaic tetracycline resistance gene tet(S/M) detected in an MDR pneumococcal CC230 lineage that underwent capsular switching in South Africa.
    J Antimicrob Chemother. 2019 Dec 2. pii: 5650366. doi: 10.1093.
    PubMed     Abstract available


  218. HAYAKAWA K, Nakano R, Hase R, Shimatani M, et al
    Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae.
    J Antimicrob Chemother. 2019 Dec 2. pii: 5650359. doi: 10.1093.
    PubMed     Abstract available


  219. SAVOLDI A, Carrara E, Gladstone BP, Azzini AM, et al
    Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list.
    J Antimicrob Chemother. 2019;74:3619-3625.
    PubMed     Abstract available


    November 2019
  220. KIM HW, Seok YS, Rhee MS
    Synergistic staphylocidal interaction of benzoic acid derivatives (benzoic acid, 4-hydroxybenzoic acid and beta-resorcylic acid) and capric acid: mechanism and verification study using artificial skin.
    J Antimicrob Chemother. 2019 Nov 28. pii: 5645158. doi: 10.1093.
    PubMed     Abstract available


  221. SUN L, Chen Y, Hua X, Chen Y, et al
    Tandem amplification of the vanM gene cluster drives vancomycin resistance in vancomycin-variable enterococci.
    J Antimicrob Chemother. 2019 Nov 19. pii: 5632032. doi: 10.1093.
    PubMed     Abstract available


  222. LESTER R, Musicha P, van Ginneken N, Dramowski A, et al
    Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review.
    J Antimicrob Chemother. 2019 Nov 19. pii: 5632029. doi: 10.1093.
    PubMed     Abstract available


  223. VAN DER LINDEN M, Mamede R, Levina N, Helwig P, et al
    Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany.
    J Antimicrob Chemother. 2019 Nov 18. pii: 5628284. doi: 10.1093.
    PubMed     Abstract available


  224. ZHANG Y, Jin L, Ouyang P, Wang Q, et al
    Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis.
    J Antimicrob Chemother. 2019 Nov 12. pii: 5622907. doi: 10.1093.
    PubMed     Abstract available


  225. VALANEJAD S, Hill B
    Treatment failure of daptomycin for Streptococcus parasanguinis meningitis.
    J Antimicrob Chemother. 2019 Nov 7. pii: 5614368. doi: 10.1093.
    PubMed    


  226. LI D, Cheng Y, Schwarz S, Yang M, et al
    Identification of a poxtA- and cfr-carrying multiresistant Enterococcus hirae strain.
    J Antimicrob Chemother. 2019 Nov 6. pii: 5613772. doi: 10.1093.
    PubMed    


    October 2019
  227. BEREDAKI MI, Georgiou PC, Siopi M, Kanioura L, et al
    Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model.
    J Antimicrob Chemother. 2019 Oct 29. pii: 5609145. doi: 10.1093.
    PubMed     Abstract available


  228. PEREZ-ALBA E, Bocanegra-Ibarias P, Garza-Gonzalez E, Martinez-Ponce de Leon AR, et al
    Comment on: Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.
    J Antimicrob Chemother. 2019 Oct 26. pii: 5607519. doi: 10.1093.
    PubMed    


  229. BRITTO CD, Dyson ZA, Mathias S, Bosco A, et al
    Persistent circulation of a fluoroquinolone-resistant Salmonella enterica Typhi clone in the Indian subcontinent.
    J Antimicrob Chemother. 2019 Oct 26. pii: 5607520. doi: 10.1093.
    PubMed     Abstract available


  230. JAHAN MI, Rahaman MM, Hossain MA, Sultana M, et al
    Occurrence of intI1-associated VIM-5 carbapenemase and co-existence of all four classes of beta-lactamase in carbapenem-resistant clinical Pseudomonas aeruginosa DMC-27b.
    J Antimicrob Chemother. 2019 Oct 24. pii: 5606763. doi: 10.1093.
    PubMed     Abstract available


  231. URUSHIBARA N, Aung MS, Kawaguchiya M, Kobayashi N, et al
    Novel staphylococcal cassette chromosome mec (SCCmec) type XIV (5A) and a truncated SCCmec element in SCC composite islands carrying speG in ST5 MRSA in Japan.
    J Antimicrob Chemother. 2019 Oct 16. pii: 5588584. doi: 10.1093.
    PubMed     Abstract available


  232. ROCH M, Varela MC, Taglialegna A, Rosato AE, et al
    Tedizolid is a promising antimicrobial option for the treatment of Staphylococcus aureus infections in cystic fibrosis patients.
    J Antimicrob Chemother. 2019 Oct 16. pii: 5588582. doi: 10.1093.
    PubMed     Abstract available


  233. FREITAS AR, Novais C, Coque TM, Peixe L, et al
    Comment on: Emergence of plasmid-mediated oxazolidinone resistance gene poxtA from CC17 Enterococcus faecium of pig origin.
    J Antimicrob Chemother. 2019 Oct 16. pii: 5588578. doi: 10.1093.
    PubMed    


  234. BIRGY A, Madhi F, Jung C, Levy C, et al
    Diversity and trends in population structure of ESBL-producing Enterobacteriaceae in febrile urinary tract infections in children in France from 2014 to 2017.
    J Antimicrob Chemother. 2019 Oct 16. pii: 5588579. doi: 10.1093.
    PubMed     Abstract available


  235. ELGHAIEB H, Tedim AP, Abbassi MS, Novais C, et al
    From farm to fork: identical clones and Tn6674-like elements in linezolid-resistant Enterococcus faecalis from food-producing animals and retail meat.
    J Antimicrob Chemother. 2019 Oct 11. pii: 5585955. doi: 10.1093.
    PubMed     Abstract available


  236. NISHIMOTO AT, Sharma C, Rogers PD
    Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.
    J Antimicrob Chemother. 2019 Oct 11. pii: 5585656. doi: 10.1093.
    PubMed     Abstract available


  237. MELLO SS, Van Tyne D, Lebreton F, Silva SQ, et al
    A mutation in the glycosyltransferase gene lafB causes daptomycin hypersusceptibility in Enterococcus faecium.
    J Antimicrob Chemother. 2019 Oct 5. pii: 5581810. doi: 10.1093.
    PubMed     Abstract available


  238. VARMA GYN, Kummari G, Paik P, Kalle AM, et al
    Celecoxib potentiates antibiotic uptake by altering membrane potential and permeability in Staphylococcus aureus.
    J Antimicrob Chemother. 2019 Oct 5. pii: 5581809. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  239. TOTH Z, Forgacs L, Locke JB, Kardos G, et al
    In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae.
    J Antimicrob Chemother. 2019 Sep 20. pii: 5572326. doi: 10.1093.
    PubMed     Abstract available


  240. PEIFFER-SMADJA N, Guillotel E, Luque-Paz D, Maataoui N, et al
    In vitro bactericidal activity of amoxicillin combined with different cephalosporins against endocarditis-associated Enterococcus faecalis clinical isolates.
    J Antimicrob Chemother. 2019 Sep 8. pii: 5565277. doi: 10.1093.
    PubMed     Abstract available


  241. ANTONELLI A, Giani T, Coppi M, Di Pilato V, et al
    Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates.
    J Antimicrob Chemother. 2019 Sep 6. pii: 5563998. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  242. EIGENBROD T, Reuter S, Gross A, Kocer K, et al
    Molecular characterization of carbapenem-resistant Acinetobacter baumannii using WGS revealed missed transmission events in Germany from 2012-15.
    J Antimicrob Chemother. 2019 Aug 31. pii: 5557811. doi: 10.1093.
    PubMed     Abstract available


  243. WARDENBURG KE, Potter RF, D'Souza AW, Hussain T, et al
    Phenotypic and genotypic characterization of linezolid-resistant Enterococcus faecium from the USA and Pakistan.
    J Antimicrob Chemother. 2019 Aug 23. pii: 5553751. doi: 10.1093.
    PubMed     Abstract available


  244. COOMBS GW, Mowlaboccus S, Daley D, Lee T, et al
    Sulfamethoxazole/trimethoprim resistance overcall by VITEK(R) 2 and BD Phoenix in community-associated MRSA and MSSA.
    J Antimicrob Chemother. 2019 Aug 20. pii: 5552317. doi: 10.1093.
    PubMed    


  245. BOJANG A, Baines SL, Donovan L, Guerillot R, et al
    Genomic investigation of Staphylococcus aureus recovered from Gambian women and newborns following an oral dose of intra-partum azithromycin.
    J Antimicrob Chemother. 2019 Aug 19. pii: 5551401. doi: 10.1093.
    PubMed     Abstract available


  246. TEN OEVER J, Jansen JL, van der Vaart TW, Schouten JA, et al
    Development of quality indicators for the management of Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2019 Aug 8. pii: 5545103. doi: 10.1093.
    PubMed     Abstract available


  247. FULLER J, Dingle TC, Bull A, Shokoples S, et al
    Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011-16 study.
    J Antimicrob Chemother. 2019;74.
    PubMed     Abstract available


  248. GOLDEN AR, Baxter MR, Davidson RJ, Martin I, et al
    Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007-16.
    J Antimicrob Chemother. 2019;74.
    PubMed     Abstract available


  249. LAGACE-WIENS PRS, Adam HJ, Poutanen S, Baxter MR, et al
    Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16.
    J Antimicrob Chemother. 2019;74.
    PubMed     Abstract available


  250. MCCRACKEN MG, Adam HJ, Blondeau JM, Walkty AJ, et al
    Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study.
    J Antimicrob Chemother. 2019;74.
    PubMed     Abstract available


    July 2019
  251. COLLEY T, Sharma C, Alanio A, Kimura G, et al
    Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus.
    J Antimicrob Chemother. 2019 Jul 30. pii: 5540742. doi: 10.1093.
    PubMed     Abstract available


  252. COUPRI D, Budin-Verneuil A, Hartke A, Benachour A, et al
    Genetic and pharmacological inactivation of d-alanylation of teichoic acids sensitizes pathogenic enterococci to beta-lactams.
    J Antimicrob Chemother. 2019 Jul 24. pii: 5538001. doi: 10.1093.
    PubMed     Abstract available


  253. LIAO X, Yang RS, Xia J, Chen L, et al
    High colonization rate of a novel carbapenem-resistant Klebsiella lineage among migratory birds at Qinghai Lake, China.
    J Antimicrob Chemother. 2019 Jul 24. pii: 5538005. doi: 10.1093.
    PubMed     Abstract available


  254. KLARE I, Bender JK, Fleige C, Kriebel N, et al
    Comparison of VITEK(R) 2, three different gradient strip tests and broth microdilution for detecting vanB-positive Enterococcus faecium isolates with low vancomycin MICs.
    J Antimicrob Chemother. 2019 Jul 23. pii: 5537362. doi: 10.1093.
    PubMed     Abstract available


  255. RUDRAMURTHY SM, Colley T, Abdolrasouli A, Ashman J, et al
    In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris.
    J Antimicrob Chemother. 2019 Jul 19. pii: 5536332. doi: 10.1093.
    PubMed     Abstract available


  256. SHANG Y, Li D, Hao W, Schwarz S, et al
    A prophage and two ICESa2603-family integrative and conjugative elements (ICEs) carrying optrA in Streptococcus suis.
    J Antimicrob Chemother. 2019 Jul 17. pii: 5533309. doi: 10.1093.
    PubMed     Abstract available


  257. HURLEY JC
    Studies of selective digestive decontamination as a natural experiment to evaluate topical antibiotic prophylaxis and cephalosporin use as population-level risk factors for enterococcal bacteraemia among ICU patients.
    J Antimicrob Chemother. 2019 Jul 17. pii: 5533112. doi: 10.1093.
    PubMed     Abstract available


  258. DUSS FR, Garcia de la Maria C, Croxatto A, Giulieri S, et al
    Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report.
    J Antimicrob Chemother. 2019 Jul 11. pii: 5531247. doi: 10.1093.
    PubMed     Abstract available


  259. MEHTA K, Ravimohan S, Pasipanodya JG, Srivastava S, et al
    Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study.
    J Antimicrob Chemother. 2019 Jul 4. pii: 5528382. doi: 10.1093.
    PubMed     Abstract available


  260. PI R, Liu Q, Jiang Q, Gao Q, et al
    Characterization of linezolid-resistance-associated mutations in Mycobacterium tuberculosis through WGS.
    J Antimicrob Chemother. 2019;74:1795-1798.
    PubMed     Abstract available


  261. WURSTER S, Bandi A, Beyda ND, Albert ND, et al
    Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.
    J Antimicrob Chemother. 2019;74:1904-1910.
    PubMed     Abstract available


  262. GONZALEZ-LARA MF, Roman-Montes CM, Diaz-Lomeli P, Rangel-Cordero A, et al
    Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico.
    J Antimicrob Chemother. 2019;74:2047-2050.
    PubMed     Abstract available


  263. PITT R, Sadouki Z, Town K, Fifer H, et al
    Detection of tet(M) in high-level tetracycline-resistant Neisseria gonorrhoeae.
    J Antimicrob Chemother. 2019;74:2115-2116.
    PubMed    


    June 2019
  264. ELGHAIEB H, Freitas AR, Abbassi MS, Novais C, et al
    Dispersal of linezolid-resistant enterococci carrying poxtA or optrA in retail meat and food-producing animals from Tunisia.
    J Antimicrob Chemother. 2019 Jun 26. pii: 5523711. doi: 10.1093.
    PubMed     Abstract available


  265. CHANCHAITHONG P, Perreten V, Schwendener S
    Macrococcus canis contains recombinogenic methicillin resistance elements and the mecB plasmid found in Staphylococcus aureus.
    J Antimicrob Chemother. 2019 Jun 26. pii: 5523695. doi: 10.1093.
    PubMed     Abstract available


  266. HUANG J, Wang M, Gao Y, Chen L, et al
    Emergence of plasmid-mediated oxazolidinone resistance gene poxtA from CC17 Enterococcus faecium of pig origin.
    J Antimicrob Chemother. 2019 Jun 24. pii: 5522517. doi: 10.1093.
    PubMed     Abstract available


  267. RESENDIZ-SHARPE A, Mercier T, Lestrade PPA, van der Beek MT, et al
    Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients.
    J Antimicrob Chemother. 2019 Jun 24. pii: 5522515. doi: 10.1093.
    PubMed     Abstract available


  268. LEON-SAMPEDRO R, Fernandez-de-Bobadilla MD, San Millan A, Baquero F, et al
    Transfer dynamics of Tn6648, a composite integrative conjugative element generated by tandem accretion of Tn5801 and Tn6647 in Enterococcus faecalis.
    J Antimicrob Chemother. 2019 Jun 21. pii: 5521775. doi: 10.1093.
    PubMed     Abstract available


  269. LENHARD JR, Smith NM, Quach CD, Nguyen TQ, et al
    Bacterial brothers in arms: cooperation of Staphylococcus aureus and Pseudomonas aeruginosa during antimicrobial exposure.
    J Antimicrob Chemother. 2019 Jun 20. pii: 5521061. doi: 10.1093.
    PubMed     Abstract available


  270. SHEN P, Zhou K, Wang Y, Song J, et al
    High prevalence of a globally disseminated hypervirulent clone, Staphylococcus aureus CC121, with reduced vancomycin susceptibility in community settings in China.
    J Antimicrob Chemother. 2019 Jun 15. pii: 5519372. doi: 10.1093.
    PubMed     Abstract available


  271. LUNA BM, Ershova K, Yan J, Ulhaq A, et al
    Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria.
    J Antimicrob Chemother. 2019 Jun 6. pii: 5512099. doi: 10.1093.
    PubMed     Abstract available


  272. HANRAHAN JK, Hogan TR, Buckley C, Trembizki E, et al
    Emergence and spread of ciprofloxacin-resistant Neisseria gonorrhoeae in New South Wales, Australia: lessons from history.
    J Antimicrob Chemother. 2019 Jun 6. pii: 5512101. doi: 10.1093.
    PubMed     Abstract available


  273. CUSACK TP, Phimolsarnnousith V, Duangmala K, Phoumin P, et al
    Molecular characterization of carbapenem-resistant Escherichia coli and Acinetobacter baumannii in the Lao People's Democratic Republic.
    J Antimicrob Chemother. 2019 Jun 5. pii: 5511712. doi: 10.1093.
    PubMed    


    May 2019
  274. PINTO SN, Dias SA, Cruz AF, Mil-Homens D, et al
    The mechanism of action of pepR, a viral-derived peptide, against Staphylococcus aureus biofilms.
    J Antimicrob Chemother. 2019 May 24. pii: 5498604. doi: 10.1093.
    PubMed     Abstract available


  275. JAJOU R, van der Laan T, de Zwaan R, Kamst M, et al
    WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing.
    J Antimicrob Chemother. 2019 May 22. pii: 5497435. doi: 10.1093.
    PubMed     Abstract available


  276. CHANG SC, Lin LC, Ge MC, Liu TP, et al
    Characterization of a novel, type II staphylococcal cassette chromosome mec element from an endemic oxacillin-resistant Staphylococcus lugdunensis clone in a hospital setting.
    J Antimicrob Chemother. 2019 May 18. pii: 5491489. doi: 10.1093.
    PubMed     Abstract available


  277. MORIO F, Lombardi L, Binder U, Loge C, et al
    Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis.
    J Antimicrob Chemother. 2019 May 18. pii: 5491491. doi: 10.1093.
    PubMed     Abstract available


  278. MELETIADIS J, Siopi M, Kanioura L, Jorgensen KM, et al
    Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.
    J Antimicrob Chemother. 2019 May 18. pii: 5491493. doi: 10.1093.
    PubMed     Abstract available


  279. LEI CW, Kang ZZ, Wu SK, Chen YP, et al
    Detection of the phenicol-oxazolidinone-tetracycline resistance gene poxtA in Enterococcus faecium and Enterococcus faecalis of food-producing animal origin in China.
    J Antimicrob Chemother. 2019 May 18. pii: 5491555. doi: 10.1093.
    PubMed    


  280. YUSTE JR, Serrano-Alonso M, Carmona-Torre F, Del Pozo JL, et al
    Efficacy and safety of long-term use of tedizolid after liver transplantation in an adolescent with pulmonary tuberculosis.
    J Antimicrob Chemother. 2019 May 18. pii: 5491490. doi: 10.1093.
    PubMed    


  281. BOEL JB, Jansaker F, Hertz FB, Hansen KH, et al
    Treatment duration of pivmecillinam in men, non-pregnant and pregnant women for community-acquired urinary tract infections caused by Escherichia coli: a retrospective Danish cohort study.
    J Antimicrob Chemother. 2019 May 16. pii: 5490639. doi: 10.1093.
    PubMed     Abstract available


  282. DUDIUK C, Berrio I, Leonardelli F, Morales-Lopez S, et al
    Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris.
    J Antimicrob Chemother. 2019 May 12. pii: 5488498. doi: 10.1093.
    PubMed     Abstract available


  283. REED JM, Gardner SG, Mishra NN, Bayer AS, et al
    Metabolic interventions for the prevention and treatment of daptomycin non-susceptibility in Staphylococcus aureus.
    J Antimicrob Chemother. 2019 May 10. pii: 5487738. doi: 10.1093.
    PubMed     Abstract available


  284. LORENZO MP, Kidd JM, Jenkins SG, Nicolau DP, et al
    In vitro activity of ampicillin and ceftriaxone against ampicillin-susceptible Enterococcus faecium.
    J Antimicrob Chemother. 2019 May 3. pii: 5485296. doi: 10.1093.
    PubMed     Abstract available


  285. BARMAN TK, Kumar M, Chaira T, Gangadharan R, et al
    Potential of the fluoroketolide RBx 14255 against Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae in an experimental murine meningitis model.
    J Antimicrob Chemother. 2019 May 2. pii: 5485015. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  286. LAVERGNE RA, Morio F, Danner-Boucher I, Horeau-Langlard D, et al
    One year prospective survey of azole resistance in Aspergillus fumigatus at a French cystic fibrosis reference centre: prevalence and mechanisms of resistance.
    J Antimicrob Chemother. 2019 Apr 30. pii: 5481886. doi: 10.1093.
    PubMed     Abstract available


  287. PAPAGIANNITSIS CC, Tsilipounidaki K, Malli E, Petinaki E, et al
    Detection in Greece of a clinical Enterococcus faecium isolate carrying the novel oxazolidinone resistance gene poxtA.
    J Antimicrob Chemother. 2019 Apr 22. pii: 5476265. doi: 10.1093.
    PubMed    


  288. AMBROSE SJ, Hall RM
    Novel trimethoprim resistance gene, dfrA35, in IncC plasmids from Australia.
    J Antimicrob Chemother. 2019 Apr 15. pii: 5464311. doi: 10.1093.
    PubMed     Abstract available


  289. DEL BARRIO-TOFINO E, Zamorano L, Cortes-Lara S, Lopez-Causape C, et al
    Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology.
    J Antimicrob Chemother. 2019 Apr 15. pii: 5464315. doi: 10.1093.
    PubMed     Abstract available


  290. WICHA WW, Strickmann DB, Paukner S
    Pharmacokinetics/pharmacodynamics of lefamulin in a neutropenic murine pneumonia model with Staphylococcus aureus and Streptococcus pneumoniae.
    J Antimicrob Chemother. 2019;74.
    PubMed     Abstract available


    March 2019
  291. PINHOLT M, Bayliss SC, Gumpert H, Worning P, et al
    WGS of 1058 Enterococcus faecium from Copenhagen, Denmark, reveals rapid clonal expansion of vancomycin-resistant clone ST80 combined with widespread dissemination of a vanA-containing plasmid and acquisition of a heterogeneous accessory genome.
    J Antimicrob Chemother. 2019 Mar 30. pii: 5423852. doi: 10.1093.
    PubMed     Abstract available


  292. SASSI M, Guerin F, Zouari A, Beyrouthy R, et al
    Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006-16.
    J Antimicrob Chemother. 2019 Mar 20. pii: 5416192. doi: 10.1093.
    PubMed     Abstract available


  293. RIVERO-MENENDEZ O, Cuenca-Estrella M, Alastruey-Izquierdo A
    In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies.
    J Antimicrob Chemother. 2019 Mar 19. pii: 5396709. doi: 10.1093.
    PubMed     Abstract available


  294. HAO W, Shan X, Li D, Schwarz S, et al
    Analysis of a poxtA- and optrA-co-carrying conjugative multiresistance plasmid from Enterococcus faecalis.
    J Antimicrob Chemother. 2019 Mar 19. pii: 5396705. doi: 10.1093.
    PubMed     Abstract available


  295. VASUDEVAN S, Durai RD, Chellappan DR, Narayanan VHB, et al
    A polymer-based anti-quorum catheter coating to challenge MDR Staphylococcus aureus: in vivo and in vitro approaches.
    J Antimicrob Chemother. 2019 Mar 12. pii: 5377359. doi: 10.1093.
    PubMed     Abstract available


  296. HASMAN H, Clausen PTLC, Kaya H, Hansen F, et al
    LRE-Finder, a Web tool for detection of the 23S rRNA mutations and the optrA, cfr, cfr(B) and poxtA genes encoding linezolid resistance in enterococci from whole-genome sequences.
    J Antimicrob Chemother. 2019 Mar 12. pii: 5377356. doi: 10.1093.
    PubMed     Abstract available


  297. TIETGEN M, Kramer JS, Brunst S, Djahanschiri B, et al
    Identification of the novel class D beta-lactamase OXA-679 involved in carbapenem resistance in Acinetobacter calcoaceticus.
    J Antimicrob Chemother. 2019 Mar 7. pii: 5371188. doi: 10.1093.
    PubMed     Abstract available


  298. KUMBURU HH, Sonda T, van Zwetselaar M, Leekitcharoenphon P, et al
    Using WGS to identify antibiotic resistance genes and predict antimicrobial resistance phenotypes in MDR Acinetobacter baumannii in Tanzania.
    J Antimicrob Chemother. 2019 Mar 6. pii: 5370329. doi: 10.1093.
    PubMed     Abstract available


  299. MAXWELL-SCOTT H, Thangarajah R, Arnold A, Wade P, et al
    Successful treatment of Pseudomonas aeruginosa infective endocarditis via haemodialysis outpatient parenteral antimicrobial therapy: case report.
    J Antimicrob Chemother. 2019 Mar 4. pii: 5369201. doi: 10.1093.
    PubMed    


  300. JIAN MJ, Cheng YH, Chung HY, Cheng YH, et al
    Fluoroquinolone resistance in carbapenem-resistant Elizabethkingia anophelis: phenotypic and genotypic characteristics of clinical isolates with topoisomerase mutations and comparative genomic analysis.
    J Antimicrob Chemother. 2019 Mar 4. pii: 5369197. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  301. GIANECINI RA, Golparian D, Zittermann S, Litvik A, et al
    Genome-based epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates with decreased susceptibility and resistance to extended-spectrum cephalosporins in Argentina in 2011-16.
    J Antimicrob Chemother. 2019 Feb 28. pii: 5366949. doi: 10.1093.
    PubMed     Abstract available


  302. PERISELNERIS J, Nwankwo L, Schelenz S, Shah A, et al
    Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
    J Antimicrob Chemother. 2019 Feb 25. pii: 5364630. doi: 10.1093.
    PubMed     Abstract available


  303. FARHAT MR, Sixsmith J, Calderon R, Hicks ND, et al
    Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates.
    J Antimicrob Chemother. 2019 Feb 21. pii: 5359497. doi: 10.1093.
    PubMed     Abstract available


  304. HU Y, Pertinez H, Liu Y, Davies G, et al
    Bedaquiline kills persistent Mycobacterium tuberculosis with no disease relapse: an in vivo model of a potential cure.
    J Antimicrob Chemother. 2019 Feb 20. pii: 5353164. doi: 10.1093.
    PubMed     Abstract available


  305. KANG J, Dietz MJ, Hughes K, Xing M, et al
    Silver nanoparticles present high intracellular and extracellular killing against Staphylococcus aureus.
    J Antimicrob Chemother. 2019 Feb 18. pii: 5333167. doi: 10.1093.
    PubMed     Abstract available


  306. BA X, Kalmar L, Hadjirin NF, Kerschner H, et al
    Truncation of GdpP mediates beta-lactam resistance in clinical isolates of Staphylococcus aureus.
    J Antimicrob Chemother. 2019 Feb 12. pii: 5316432. doi: 10.1093.
    PubMed     Abstract available


  307. SINGH A, Singh PK, de Groot T, Kumar A, et al
    Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India.
    J Antimicrob Chemother. 2019 Feb 11. pii: 5315659. doi: 10.1093.
    PubMed     Abstract available


  308. LAMOTH F, Mercier T, Andre P, Pagani JL, et al
    Isavuconazole brain penetration in cerebral aspergillosis.
    J Antimicrob Chemother. 2019 Feb 11. pii: 5315664. doi: 10.1093.
    PubMed    


  309. NIKOLAYEVSKYY V, Maurer FP, Holicka Y, Taylor L, et al
    Novel external quality assurance scheme for drug susceptibility testing of non-tuberculous mycobacteria: a multicentre pilot study.
    J Antimicrob Chemother. 2019 Feb 11. pii: 5315667. doi: 10.1093.
    PubMed     Abstract available


  310. WU T, Meyer K, Harrington AT, Danziger LH, et al
    In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci.
    J Antimicrob Chemother. 2019 Feb 8. pii: 5310330. doi: 10.1093.
    PubMed     Abstract available


  311. DAS S, Garg T, Chopra S, Dasgupta A, et al
    Repurposing disulfiram to target infections caused by non-tuberculous mycobacteria.
    J Antimicrob Chemother. 2019 Feb 7. pii: 5309031. doi: 10.1093.
    PubMed     Abstract available


  312. SADER HS, Mendes RE, Pfaller MA, Flamm RK, et al
    Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centres.
    J Antimicrob Chemother. 2019 Feb 7. pii: 5309029. doi: 10.1093.
    PubMed     Abstract available


  313. PAUL S, Singh S, Chakrabarti A, Rudramurthy SM, et al
    Stable isotope labelling: an approach for MALDI-TOF MS-based rapid detection of fluconazole resistance in Candida tropicalis.
    J Antimicrob Chemother. 2019 Feb 6. pii: 5307967. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  314. PEREZ-RODRIGUEZ MT, Sousa A, Lopez-Cortes LE, Martinez-Lamas L, et al
    Moving beyond unsolicited consultation: additional impact of a structured intervention on mortality in Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2019 Jan 27. pii: 5303230. doi: 10.1093.
    PubMed     Abstract available


  315. DEL PRINCIPE MI, Dragonetti G, Verga L, Candoni A, et al
    'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study.
    J Antimicrob Chemother. 2019 Jan 14. pii: 5289513. doi: 10.1093.
    PubMed     Abstract available


  316. KITAMURA M, Kimura K, Ido A, Seki T, et al
    Relatively high rates of cefotaxime- and ceftriaxone-non-susceptible isolates among group B streptococci with reduced penicillin susceptibility (PRGBS) in Japan.
    J Antimicrob Chemother. 2019 Jan 11. pii: 5288581. doi: 10.1093.
    PubMed     Abstract available


  317. MORRONI G, Brenciani A, Litta-Mulondo A, Vignaroli C, et al
    Characterization of a new transferable MDR plasmid carrying the pbp5 gene from a clade B commensal Enterococcus faecium.
    J Antimicrob Chemother. 2019 Jan 10. pii: 5288148. doi: 10.1093.
    PubMed     Abstract available


  318. RUTH MM, Sangen JJN, Remmers K, Pennings LJ, et al
    A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
    J Antimicrob Chemother. 2019 Jan 10. pii: 5288158. doi: 10.1093.
    PubMed     Abstract available


  319. JUHAS M, Widlake E, Teo J, Huseby DL, et al
    In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii.
    J Antimicrob Chemother. 2019 Jan 9. pii: 5284660. doi: 10.1093.
    PubMed     Abstract available


  320. DE JONG A, Simjee S, Rose M, Moyaert H, et al
    Antimicrobial resistance monitoring in commensal enterococci from healthy cattle, pigs and chickens across Europe during 2004-14 (EASSA Study).
    J Antimicrob Chemother. 2019 Jan 8. pii: 5280942. doi: 10.1093.
    PubMed     Abstract available


    December 2018
  321. KOSMIDIS C, Rodriguez-Goncer I, Rautemaa-Richardson R, Richardson MD, et al
    Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis.
    J Antimicrob Chemother. 2018 Dec 26. pii: 5262264. doi: 10.1093.
    PubMed     Abstract available


  322. MACFADYEN AC, Harrison EM, Drigo I, Parkhill J, et al
    A mecC allotype, mecC3, in the CoNS Staphylococcus caeli, encoded within a variant SCCmecC.
    J Antimicrob Chemother. 2018 Dec 22. pii: 5258045. doi: 10.1093.
    PubMed     Abstract available


  323. RYBAK JM, Fortwendel JR, Rogers PD
    Emerging threat of triazole-resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2018 Dec 17. pii: 5250853. doi: 10.1093.
    PubMed     Abstract available


  324. KIDD JM, Abdelraouf K, Nicolau DP
    Comparative efficacy of human-simulated epithelial lining fluid exposures of tedizolid, linezolid and vancomycin in neutropenic and immunocompetent murine models of staphylococcal pneumonia.
    J Antimicrob Chemother. 2018 Dec 14. pii: 5248203. doi: 10.1093.
    PubMed     Abstract available


  325. MARQUES C, Menezes J, Belas A, Aboim C, et al
    Klebsiella pneumoniae causing urinary tract infections in companion animals and humans: population structure, antimicrobial resistance and virulence genes.
    J Antimicrob Chemother. 2018 Dec 10. pii: 5237779. doi: 10.1093.
    PubMed     Abstract available


  326. EILERTSON B
    CG258 Klebsiella pneumoniae isolates without beta-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City-author response.
    J Antimicrob Chemother. 2018 Dec 5. pii: 5231911. doi: 10.1093.
    PubMed    


  327. BRENCIANI A, Fioriti S, Morroni G, Cucco L, et al
    Detection in Italy of a porcine Enterococcus faecium isolate carrying the novel phenicol-oxazolidinone-tetracycline resistance gene poxtA.
    J Antimicrob Chemother. 2018 Dec 4. pii: 5230877. doi: 10.1093.
    PubMed    


  328. ABAD L, Tafani V, Tasse J, Josse J, et al
    Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting.
    J Antimicrob Chemother. 2018 Dec 4. pii: 5230874. doi: 10.1093.
    PubMed     Abstract available


  329. ACCOCEBERRY I, Couzigou C, Fitton-Ouhabi V, Biteau N, et al
    Challenging SNP impact on caspofungin resistance by full-length FKS1 allele replacement in Candida lusitaniae.
    J Antimicrob Chemother. 2018 Dec 4. pii: 5230873. doi: 10.1093.
    PubMed     Abstract available


  330. AKKERMAN OW, Alffenaar JWC
    Comment on: The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.
    J Antimicrob Chemother. 2018 Dec 1. pii: 5224542. doi: 10.1093.
    PubMed    


    November 2018
  331. WYRES KL, Lam MMC, Holt KE
    Comment on: CG258 Klebsiella pneumoniae isolates without beta-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City.
    J Antimicrob Chemother. 2018 Nov 30. pii: 5224781. doi: 10.1093.
    PubMed    


  332. PULCINI C, Clerc-Urmes I, Attinsounon CA, Fougnot S, et al
    Antibiotic resistance of Enterobacteriaceae causing urinary tract infections in elderly patients living in the community and in the nursing home: a retrospective observational study.
    J Antimicrob Chemother. 2018 Nov 30. pii: 5224777. doi: 10.1093.
    PubMed     Abstract available


  333. DENISUIK AJ, Garbutt LA, Golden AR, Adam HJ, et al
    Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study.
    J Antimicrob Chemother. 2018 Nov 29. pii: 5219007. doi: 10.1093.
    PubMed     Abstract available


  334. JIANG N, Li J, Fessler AT, Wang Y, et al
    Novel pseudo-staphylococcal cassette chromosome mec element (phiSCCmecT55) in MRSA ST9.
    J Antimicrob Chemother. 2018 Nov 15. pii: 5184555. doi: 10.1093.
    PubMed    


  335. TREVINO-RANGEL RJ, Villanueva-Lozano H, Mendez-Galomo KS, Solis-Villegas EM, et al
    In vivo evaluation of the antifungal activity of sertraline against Aspergillus fumigatus.
    J Antimicrob Chemother. 2018 Nov 6. pii: 5162960. doi: 10.1093.
    PubMed     Abstract available


  336. LACKNER M, Birch M, Naschberger V, Grassle D, et al
    Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei.
    J Antimicrob Chemother. 2018;73:3068-3073.
    PubMed     Abstract available


    October 2018
  337. DAS S, Li J, Iaconis J, Zhou D, et al
    Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections.
    J Antimicrob Chemother. 2018 Oct 31. pii: 5150590. doi: 10.1093.
    PubMed     Abstract available


  338. NADERI J, Giles C, Saboohi S, Griesser HJ, et al
    Surface coatings with covalently attached anidulafungin and micafungin prevent Candida albicans biofilm formation.
    J Antimicrob Chemother. 2018 Oct 29. pii: 5146520. doi: 10.1093.
    PubMed     Abstract available


  339. TROEMAN DPR, Van Hout D, Kluytmans JAJW
    Antimicrobial approaches in the prevention of Staphylococcus aureus infections: a review.
    J Antimicrob Chemother. 2018 Oct 29. pii: 5146516. doi: 10.1093.
    PubMed     Abstract available


  340. LOPEZ B, Siqueira de Oliveira R, Pinhata JMW, Chimara E, et al
    Bedaquiline and linezolid MIC distributions and epidemiological cut-off values for Mycobacterium tuberculosis in the Latin American region.
    J Antimicrob Chemother. 2018 Oct 25. pii: 5144701. doi: 10.1093.
    PubMed     Abstract available


  341. HSUEH SC, Lee YJ, Huang YT, Liao CH, et al
    In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstr
    J Antimicrob Chemother. 2018 Oct 23. pii: 5144002. doi: 10.1093.
    PubMed     Abstract available


  342. BROSH-NISSIMOV T, Navon-Venezia S, Keller N, Amit S, et al
    Risk analysis of antimicrobial resistance in outpatient urinary tract infections of young healthy adults.
    J Antimicrob Chemother. 2018 Oct 23. pii: 5144000. doi: 10.1093.
    PubMed     Abstract available


  343. CAMPBELL AJ, Dotel R, Blyth CC, Davis JS, et al
    Adjunctive protein synthesis inhibitor antibiotics for toxin suppression in Staphylococcus aureus infections: a systematic appraisal.
    J Antimicrob Chemother. 2018 Oct 10. pii: 5126432. doi: 10.1093.
    PubMed     Abstract available


  344. DOAN TN, Fox GJ, Meehan MT, Scott N, et al
    Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study.
    J Antimicrob Chemother. 2018 Oct 5. pii: 5116208. doi: 10.1093.
    PubMed     Abstract available


  345. TYSON GH, Sabo JL, Hoffmann M, Hsu CH, et al
    Novel linezolid resistance plasmids in Enterococcus from food animals in the USA.
    J Antimicrob Chemother. 2018 Oct 1. pii: 5106682. doi: 10.1093.
    PubMed     Abstract available


    September 2018
  346. XHEMALI X, Smith JR, Kebriaei R, Rice SA, et al
    Evaluation of dalbavancin alone and in combination with beta-lactam antibiotics against resistant phenotypes of Staphylococcus aureus.
    J Antimicrob Chemother. 2018 Sep 27. pii: 5107805. doi: 10.1093.
    PubMed     Abstract available


  347. AUTMIZGUINE J, Smith PB, Prather K, Bendel C, et al
    Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants.
    J Antimicrob Chemother. 2018 Sep 20. pii: 5104445. doi: 10.1093.
    PubMed     Abstract available


  348. ZHOU X, Chlebowicz MA, Bathoorn E, Rosema S, et al
    Elucidating vancomycin-resistant Enterococcus faecium outbreaks: the role of clonal spread and movement of mobile genetic elements.
    J Antimicrob Chemother. 2018 Sep 14. pii: 5096847. doi: 10.1093.
    PubMed     Abstract available


  349. CHANNABASAPPA S, Chikkamadaiah R, Durgaiah M, Kumar S, et al
    Efficacy of chimeric ectolysin P128 in drug-resistant Staphylococcus aureus bacteraemia in mice.
    J Antimicrob Chemother. 2018 Sep 11. pii: 5095203. doi: 10.1093.
    PubMed     Abstract available


  350. LEE RS, Goncalves da Silva A, Baines SL, Strachan J, et al
    The changing landscape of vancomycin-resistant Enterococcus faecium in Australia: a population-level genomic study.
    J Antimicrob Chemother. 2018 Sep 4. pii: 5090546. doi: 10.1093.
    PubMed     Abstract available


    August 2018
  351. PASQUAROLI S, Citterio B, Mangiaterra G, Biavasco F, et al
    Influence of sublethal concentrations of vancomycin and quinupristin/dalfopristin on the persistence of viable but non-culturable Staphylococcus aureus growing in biofilms.
    J Antimicrob Chemother. 2018 Aug 29. pii: 5086495. doi: 10.1093.
    PubMed    


  352. CAMARA J, Cubero M, Martin-Galiano AJ, Garcia E, et al
    Evolution of the beta-lactam-resistant Streptococcus pneumoniae PMEN3 clone over a 30 year period in Barcelona, Spain.
    J Antimicrob Chemother. 2018 Aug 27. pii: 5079858. doi: 10.1093.
    PubMed     Abstract available


  353. MACFADYEN AC, Harrison EM, Ellington MJ, Parkhill J, et al
    A highly conserved mecC-encoding SCCmec type XI in a bovine isolate of methicillin-resistant Staphylococcus xylosus.
    J Antimicrob Chemother. 2018 Aug 27. pii: 5084893. doi: 10.1093.
    PubMed    


  354. RIGAILL J, Morgene MF, Gavid M, Lelonge Y, et al
    Intracellular activity of antimicrobial compounds used for Staphylococcus aureus nasal decolonization.
    J Antimicrob Chemother. 2018 Aug 16. pii: 5075188. doi: 10.1093.
    PubMed     Abstract available


  355. DEPLANO A, Dodemont M, Denis O, Westh H, et al
    European external quality assessments for identification, molecular typing and characterization of Staphylococcus aureus.
    J Antimicrob Chemother. 2018 Aug 7. pii: 5067736. doi: 10.1093.
    PubMed     Abstract available


  356. HANSEN TA, Pedersen MS, Nielsen LG, Ma CMG, et al
    Emergence of a vancomycin-variable Enterococcus faecium ST1421 strain containing a deletion in vanX.
    J Antimicrob Chemother. 2018 Aug 2. pii: 5064278. doi: 10.1093.
    PubMed     Abstract available


  357. BERKOW EL, Lockhart SR
    Activity of novel antifungal compound APX001A against a large collection of Candida auris.
    J Antimicrob Chemother. 2018 Aug 1. pii: 5063540. doi: 10.1093.
    PubMed     Abstract available


    July 2018
  358. WIEDERHOLD NP, Locke JB, Daruwala P, Bartizal K, et al
    Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species.
    J Antimicrob Chemother. 2018 Jul 18. pii: 5055842. doi: 10.1093.
    PubMed     Abstract available


  359. ROGIERS O, Holtappels M, Siala W, Lamkanfi M, et al
    Anidulafungin increases the antibacterial activity of tigecycline in polymicrobial Candida albicans/Staphylococcus aureus biofilms on intraperitoneally implanted foreign bodies.
    J Antimicrob Chemother. 2018 Jul 13. pii: 5053967. doi: 10.1093.
    PubMed     Abstract available


  360. WHITFIELD MG, Warren RM, Mathys V, Scott L, et al
    The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.
    J Antimicrob Chemother. 2018 Jul 5. pii: 5049577. doi: 10.1093.
    PubMed     Abstract available


  361. GOLDEN AR, Adam HJ, Karlowsky JA, Baxter M, et al
    Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


  362. ADAM HJ, Golden AR, Karlowsky JA, Baxter MR, et al
    Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


  363. ZHANEL GG, Adam HJ
    Introduction to the SAVE study (2011-15): Streptococcus pneumoniae serotyping and antimicrobial susceptibility: Assessment for Vaccine Efficacy in Canada after the introduction of PCV-13.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


  364. KARLOWSKY JA, Adam HJ, Golden AR, Baxter MR, et al
    Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


    June 2018
  365. GARVEY EP, Sharp AD, Warn PA, Yates CM, et al
    The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis.
    J Antimicrob Chemother. 2018 Jun 26. pii: 5045560. doi: 10.1093.
    PubMed     Abstract available


  366. TAVERNIER S, Sass A, De Bruyne M, Baeke F, et al
    Decreased susceptibility of Streptococcus anginosus to vancomycin in a multispecies biofilm is due to increased thickness of the cell wall.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036452. doi: 10.1093.
    PubMed     Abstract available


  367. BOUDJEMAA R, Steenkeste K, Jacqueline C, Briandet R, et al
    Live intramacrophagic Staphylococcus aureus as a potential cause of antibiotic therapy failure: observations in an in vivo mouse model of prosthetic vascular material infections.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036450. doi: 10.1093.
    PubMed     Abstract available


  368. DESHPANDE LM, Castanheira M, Flamm RK, Mendes RE, et al
    Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program.
    J Antimicrob Chemother. 2018 Jun 6. pii: 5033815. doi: 10.1093.
    PubMed     Abstract available


    May 2018
  369. TALBOT JJ, Subedi S, Halliday CL, Hibbs DE, et al
    Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
    J Antimicrob Chemother. 2018 May 29. pii: 5018389. doi: 10.1093.
    PubMed     Abstract available


  370. ARENDRUP MC, Verweij PE, Mouton JW, Lagrou K, et al
    Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2018 May 25. pii: 5003466. doi: 10.1093.
    PubMed    


  371. BREAK TJ, Desai JV, Healey KR, Natarajan M, et al
    VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice.
    J Antimicrob Chemother. 2018 May 16. pii: 4996888. doi: 10.1093.
    PubMed     Abstract available


    April 2018
  372. SEUFERT R, Sedlacek L, Kahl B, Hogardt M, et al
    Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany.
    J Antimicrob Chemother. 2018 Apr 19. pii: 4978322. doi: 10.1093.
    PubMed     Abstract available


  373. HAGER CL, Larkin EL, Long LA, Ghannoum MA, et al
    Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model.
    J Antimicrob Chemother. 2018 Apr 19. pii: 4979534. doi: 10.1093.
    PubMed     Abstract available


  374. RIZZATO C, Poma N, Zoppo M, Posteraro B, et al
    CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates.
    J Antimicrob Chemother. 2018 Apr 9. pii: 4964989. doi: 10.1093.
    PubMed     Abstract available


  375. ARGUDIN MA, Dodemont M, Taguemount M, Roisin S, et al
    In vitro activity of ceftaroline against clinical Staphylococcus aureus isolates collected during a national survey conducted in Belgian hospitals.
    J Antimicrob Chemother. 2018 Apr 5. pii: 4962127. doi: 10.1093.
    PubMed    


  376. HASHEMI MM, Rovig J, Holden BS, Taylor MF, et al
    Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms.
    J Antimicrob Chemother. 2018 Apr 4. pii: 4960903. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  377. CANEZIN PH, Caleffi-Ferracioli KR, Scodro RBL, Siqueira VLD, et al
    Intramacrophage Mycobacterium tuberculosis efflux pump gene regulation after rifampicin and verapamil exposure.
    J Antimicrob Chemother. 2018 Mar 22. pii: 4951545. doi: 10.1093.
    PubMed     Abstract available


  378. VAN HAL SJ, Beukers AG, Timms VJ, Ellem JA, et al
    Relentless spread and adaptation of non-typeable vanA vancomycin-resistant Enterococcus faecium: a genome-wide investigation.
    J Antimicrob Chemother. 2018 Mar 16. pii: 4939528. doi: 10.1093.
    PubMed     Abstract available


  379. DALL GF, Tsang SJ, Gwynne PJ, MacKenzie SP, et al
    Unexpected synergistic and antagonistic antibiotic activity against Staphylococcus biofilms.
    J Antimicrob Chemother. 2018 Mar 14. pii: 4937886. doi: 10.1093.
    PubMed     Abstract available


  380. CARTER GP, Harjani JR, Li L, Pitcher NP, et al
    1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
    J Antimicrob Chemother. 2018 Mar 6. pii: 4922693. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  381. THIEME L, Klinger-Strobel M, Hartung A, Stein C, et al
    In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis.
    J Antimicrob Chemother. 2018 Feb 28. pii: 4913717. doi: 10.1093.
    PubMed     Abstract available


  382. MCCARTY TP, Lockhart SR, Moser SA, Whiddon J, et al
    Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: analysis of trends and outcomes.
    J Antimicrob Chemother. 2018 Feb 28. pii: 4913721. doi: 10.1093.
    PubMed     Abstract available


  383. RODRIGUEZ-CASTRO E, Trastoy R, Rodriguez-Osorio X, Dominguez-Santalla MJ, et al
    Meningitis due to autochthonous acute infection with hepatitis E virus in a chef: a case report.
    J Antimicrob Chemother. 2018 Feb 21. pii: 4898172. doi: 10.1093.
    PubMed    


  384. LEBRETON F, Valentino MD, Schaufler K, Earl AM, et al
    Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium.
    J Antimicrob Chemother. 2018 Feb 14. pii: 4859672. doi: 10.1093.
    PubMed     Abstract available


  385. WESSELS C, Strommenger B, Klare I, Bender J, et al
    Emergence and control of linezolid-resistant Staphylococcus epidermidis in an ICU of a German hospital.
    J Antimicrob Chemother. 2018 Feb 9. pii: 4847818. doi: 10.1093.
    PubMed     Abstract available


  386. KAMBAREV S, Pecorari F, Corvec S
    Novel Tn916-like elements confer aminoglycoside/macrolide co-resistance in clinical isolates of Streptococcus gallolyticus ssp. gallolyticus.
    J Antimicrob Chemother. 2018 Feb 9. pii: 4847819. doi: 10.1093.
    PubMed     Abstract available


  387. SUN C, Zhang P, Ji X, Fan R, et al
    Presence and molecular characteristics of oxazolidinone resistance in staphylococci from household animals in rural China.
    J Antimicrob Chemother. 2018 Feb 7. pii: 4841776. doi: 10.1093.
    PubMed     Abstract available


  388. HUH HJ, Song DJ, Shim HJ, Kwon WK, et al
    Performance evaluation of the QMAC-dRAST for staphylococci and enterococci isolated from blood culture: a comparative study of performance with the VITEK-2 system.
    J Antimicrob Chemother. 2018 Feb 3. pii: 4837262. doi: 10.1093.
    PubMed     Abstract available


  389. NEVES FPG, Cardoso NT, Souza ARV, Snyder RE, et al
    Population structure of Streptococcus pneumoniae colonizing children before and after universal use of pneumococcal conjugate vaccines in Brazil: emergence and expansion of the MDR serotype 6C-CC386 lineage.
    J Antimicrob Chemother. 2018 Feb 1. pii: 4833983. doi: 10.1093.
    PubMed     Abstract available


    January 2018
  390. LESTRADE PP, van der Velden WJFM, Bouwman F, Stoop FJ, et al
    Epidemiology of invasive aspergillosis and triazole-resistant Aspergillus fumigatus in patients with haematological malignancies: a single-centre retrospective cohort study.
    J Antimicrob Chemother. 2018 Jan 31. pii: 4831957. doi: 10.1093.
    PubMed     Abstract available


  391. DOOKIE N, Rambaran S, Padayatchi N, Mahomed S, et al
    Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.
    J Antimicrob Chemother. 2018 Jan 19. pii: 4817621. doi: 10.1093.
    PubMed     Abstract available


  392. LAYER F, Vourli S, Karavasilis V, Strommenger B, et al
    Dissemination of linezolid-dependent, linezolid-resistant Staphylococcus epidermidis clinical isolates belonging to CC5 in German hospitals.
    J Antimicrob Chemother. 2018 Jan 19. pii: 4817623. doi: 10.1093.
    PubMed     Abstract available


  393. SASSI M, Guerin F, Lesec L, Isnard C, et al
    Genetic characterization of a VanG-type vancomycin-resistant Enterococcus faecium clinical isolate.
    J Antimicrob Chemother. 2018 Jan 16. pii: 4812002. doi: 10.1093.
    PubMed     Abstract available


  394. REISSIER S, Saleh-Mghir A, Guerin F, Massias L, et al
    In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.
    J Antimicrob Chemother. 2018 Jan 9. pii: 4796903. doi: 10.1093.
    PubMed     Abstract available


  395. CHOWDHARY A, Prakash A, Sharma C, Kordalewska M, et al
    A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    J Antimicrob Chemother. 2018 Jan 9. pii: 4794718. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  396. VAN DEN BUNT G, Top J, Hordijk J, de Greeff SC, et al
    Intestinal carriage of ampicillin- and vancomycin-resistant Enterococcus faecium in humans, dogs and cats in the Netherlands.
    J Antimicrob Chemother. 2017 Dec 25. pii: 4774625. doi: 10.1093.
    PubMed     Abstract available


  397. EDSLEV SM, Clausen ML, Agner T, Stegger M, et al
    Genomic analysis reveals different mechanisms of fusidic acid resistance in Staphylococcus aureus from Danish atopic dermatitis patients.
    J Antimicrob Chemother. 2017 Dec 14. pii: 4745837. doi: 10.1093.
    PubMed     Abstract available


  398. LIU Y, Pertinez H, Ortega-Muro F, Alameda-Martin L, et al
    Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria.
    J Antimicrob Chemother. 2017 Dec 12. pii: 4735127. doi: 10.1093.
    PubMed     Abstract available


  399. CHEN C, Hooper DC
    Effect of Staphylococcus aureus Tet38 native efflux pump on in vivo response to tetracycline in a murine subcutaneous abscess model.
    J Antimicrob Chemother. 2017 Dec 5. pii: 4693732. doi: 10.1093.
    PubMed     Abstract available


  400. ZHANG P, Wright JA, Tymon A, Nair SP, et al
    Bicarbonate induces high-level resistance to the human antimicrobial peptide LL-37 in Staphylococcus aureus small colony variants.
    J Antimicrob Chemother. 2017 Dec 4. pii: 4688916. doi: 10.1093.
    PubMed     Abstract available


    November 2017
  401. PITT R, Alexander S, Ison C, Horner P, et al
    Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections.
    J Antimicrob Chemother. 2017 Nov 30. pii: 4682922. doi: 10.1093.
    PubMed     Abstract available


  402. KONTOYIANNIS DP, Selleslag D, Mullane K, Cornely OA, et al
    Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
    J Antimicrob Chemother. 2017 Nov 29. pii: 4675068. doi: 10.1093.
    PubMed     Abstract available


  403. WIEDERHOLD NP, Patterson HP, Tran BH, Yates CM, et al
    Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus.
    J Antimicrob Chemother. 2017 Nov 27. pii: 4669681. doi: 10.1093.
    PubMed     Abstract available


  404. HOMBACH M, Jetter M, Blochliger N, Kolesnik-Goldmann N, et al
    Rapid disc diffusion antibiotic susceptibility testing for Pseudomonas aeruginosa, Acinetobacter baumannii and Enterococcus spp.
    J Antimicrob Chemother. 2017 Nov 23. pii: 4654829. doi: 10.1093.
    PubMed     Abstract available


  405. WIEDERHOLD NP, Najvar LK, Jaramillo R, Olivo M, et al
    Oral glucan synthase inhibitor SCY-078 is effective in an experimental murine model of invasive candidiasis caused by WT and echinocandin-resistant Candida glabrata.
    J Antimicrob Chemother. 2017 Nov 21. pii: 4644442. doi: 10.1093.
    PubMed     Abstract available


  406. FREITAS AR, Tedim AP, Novais C, Coque TM, et al
    Distribution of putative virulence markers in Enterococcus faecium: towards a safety profile review.
    J Antimicrob Chemother. 2017 Nov 14. doi: 10.1093.
    PubMed     Abstract available


  407. COSTA SS, Viveiros M, Pomba C, Couto I, et al
    Active antimicrobial efflux in Staphylococcus epidermidis: building up of resistance to fluoroquinolones and biocides in a major opportunistic pathogen.
    J Antimicrob Chemother. 2017 Nov 8. doi: 10.1093.
    PubMed     Abstract available


  408. GODET C, Alastruey-Izquierdo A, Flick H, Hennequin C, et al
    A CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention.
    J Antimicrob Chemother. 2017 Nov 6. doi: 10.1093.
    PubMed     Abstract available


  409. BUIL JB, Bruggemann RJM, Wasmann RE, Zoll J, et al
    Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
    J Antimicrob Chemother. 2017 Nov 3. doi: 10.1093.
    PubMed    


    October 2017
  410. DORTET L, Glaser P, Kassis-Chikhani N, Girlich D, et al
    Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France.
    J Antimicrob Chemother. 2017 Oct 30. doi: 10.1093.
    PubMed     Abstract available


  411. VYAZOVAYA A, Levina K, Zhuravlev V, Viiklepp P, et al
    Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal context.
    J Antimicrob Chemother. 2017 Oct 30. doi: 10.1093.
    PubMed     Abstract available


  412. FOSCHI C, Salvo M, Cevenini R, Marangoni A, et al
    Chlamydia trachomatis antimicrobial susceptibility in colorectal and endocervical cells.
    J Antimicrob Chemother. 2017 Oct 25. doi: 10.1093.
    PubMed     Abstract available


  413. CHEN CJ, Lauderdale TY, Lu CT, Chuang YY, et al
    Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans.
    J Antimicrob Chemother. 2017 Oct 18. doi: 10.1093.
    PubMed     Abstract available


  414. BUIL JB, Bruggemann RJM, Wasmann RE, Zoll J, et al
    Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
    J Antimicrob Chemother. 2017 Oct 18. doi: 10.1093.
    PubMed     Abstract available


  415. SEAS C, Garcia C, Salles MJ, Labarca J, et al
    Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study.
    J Antimicrob Chemother. 2017 Oct 17. doi: 10.1093.
    PubMed     Abstract available


  416. BREAK TJ, Desai JV, Natarajan M, Ferre EMN, et al
    VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
    J Antimicrob Chemother. 2017 Oct 10. doi: 10.1093.
    PubMed     Abstract available


  417. HOLYK A, Belden V, Lee JJ, Musick W, et al
    Ceftazidime/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report.
    J Antimicrob Chemother. 2017 Oct 10. doi: 10.1093.
    PubMed    


  418. ARENDRUP MC, Verweij PE, Mouton JW, Lagrou K, et al
    Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2017 Oct 4. doi: 10.1093.
    PubMed     Abstract available


  419. YEW WW, Liang D, Chan DP, Shi W, et al
    Molecular mechanisms of clofazimine resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2017;72:2943-2944.
    PubMed    


  420. SINGH R, Almutairi M, Alm RA, Lahiri SD, et al
    Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.
    J Antimicrob Chemother. 2017;72:2796-2803.
    PubMed     Abstract available


  421. SCORNEC H, Bellanger X, Guilloteau H, Groshenry G, et al
    Inducibility of Tn916 conjugative transfer in Enterococcus faecalis by subinhibitory concentrations of ribosome-targeting antibiotics.
    J Antimicrob Chemother. 2017;72:2722-2728.
    PubMed     Abstract available


  422. DOUMITH M, Mushtaq S, Martin V, Chaudhry A, et al
    Genomic sequences of Streptococcus agalactiae with high-level gentamicin resistance, collected in the BSAC bacteraemia surveillance.
    J Antimicrob Chemother. 2017;72:2704-2707.
    PubMed     Abstract available


  423. ZHANG Y, Kashikar A, Bush K
    In vitro activity of plazomicin against beta-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
    J Antimicrob Chemother. 2017;72:2792-2795.
    PubMed     Abstract available


  424. BRENNAN-KROHN T, Truelson KA, Smith KP, Kirby JE, et al
    Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.
    J Antimicrob Chemother. 2017;72:2775-2781.
    PubMed     Abstract available


    September 2017
  425. FREITAS AR, Elghaieb H, Leon-Sampedro R, Abbassi MS, et al
    Detection of optrA in the African continent (Tunisia) within a mosaic Enterococcus faecalis plasmid from urban wastewaters.
    J Antimicrob Chemother. 2017 Sep 26. doi: 10.1093.
    PubMed     Abstract available


  426. CHEN J, Zhang S, Cui P, Shi W, et al
    Identification of novel mutations associated with cycloserine resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2017 Sep 12. doi: 10.1093.
    PubMed     Abstract available


  427. WU CJ, Lai JF, Huang IW, Hsieh LY, et al
    Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan.
    J Antimicrob Chemother. 2017 Sep 6. doi: 10.1093.
    PubMed     Abstract available


  428. PASIPANODYA JG, Ogbonna D, Deshpande D, Srivastava S, et al
    Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium-intracellulare complex disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Abstract available


  429. DESHPANDE D, Srivastava S, Gumbo T
    A programme to create short-course chemotherapy for pulmonary Mycobacterium avium disease based on pharmacokinetics/pharmacodynamics and mathematical forecasting.
    J Antimicrob Chemother. 2017;72.
    PubMed     Abstract available


  430. DESHPANDE D, Srivastava S, Pasipanodya JG, Lee PS, et al
    A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Abstract available


  431. DESHPANDE D, Srivastava S, Pasipanodya JG, Lee PS, et al
    Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Abstract available


  432. DESHPANDE D, Srivastava S, Pasipanodya JG, Gumbo T, et al
    Linezolid as treatment for pulmonary Mycobacterium avium disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Abstract available


  433. SRIVASTAVA S, Deshpande D, Gumbo T
    Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance.
    J Antimicrob Chemother. 2017;72.
    PubMed     Abstract available


    August 2017
  434. LAZARIS A, Coleman DC, Kearns AM, Pichon B, et al
    Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE.
    J Antimicrob Chemother. 2017 Aug 28. doi: 10.1093.
    PubMed     Abstract available


  435. CHANG SC, Lee MH, Yeh CF, Liu TP, et al
    Characterization of two novel variants of staphylococcal cassette chromosome mec elements in oxacillin-resistant Staphylococcus lugdunensis.
    J Antimicrob Chemother. 2017 Aug 23. doi: 10.1093.
    PubMed     Abstract available


  436. GONZALEZ MORENO M, Trampuz A, Di Luca M
    Synergistic antibiotic activity against planktonic and biofilm-embedded Streptococcus agalactiae, Streptococcus pyogenes and Streptococcus oralis.
    J Antimicrob Chemother. 2017 Aug 21. doi: 10.1093.
    PubMed     Abstract available


  437. SINGH AK, Thakare R, Karaulia P, Das S, et al
    Biological evaluation of diphenyleneiodonium chloride (DPIC) as a potential drug candidate for treatment of non-tuberculous mycobacterial infections.
    J Antimicrob Chemother. 2017 Aug 17. doi: 10.1093.
    PubMed     Abstract available


  438. SCHAUWVLIEGHE AFAD, Vonk AG, Buddingh EP, Hoek RAS, et al
    Detection of azole-susceptible and azole-resistant Aspergillus coinfection by cyp51A PCR amplicon melting curve analysis.
    J Antimicrob Chemother. 2017 Aug 9. doi: 10.1093.
    PubMed     Abstract available


  439. WEBER RE, Layer F, Klare I, Werner G, et al
    Comparative evaluation of VITEK(R) 2 and three commercial gradient strip assays for daptomycin susceptibility testing of Staphylococcus aureus.
    J Antimicrob Chemother. 2017 Aug 7. doi: 10.1093.
    PubMed     Abstract available


  440. COJUTTI PG, Candoni A, Ramos-Martin V, Lazzarotto D, et al
    Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies.
    J Antimicrob Chemother. 2017;72:2342-2350.
    PubMed     Abstract available


  441. CORNELY OA, Leguay T, Maertens J, Vehreschild MJGT, et al
    Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia.
    J Antimicrob Chemother. 2017;72:2359-2367.
    PubMed     Abstract available


  442. TAUBERT M, Zander J, Frechen S, Scharf C, et al
    Optimization of linezolid therapy in the critically ill: the effect of adjusted infusion regimens.
    J Antimicrob Chemother. 2017;72:2304-2310.
    PubMed     Abstract available


  443. BEVAN ER, Jones AM, Hawkey PM
    Global epidemiology of CTX-M beta-lactamases: temporal and geographical shifts in genotype.
    J Antimicrob Chemother. 2017;72:2145-2155.
    PubMed     Abstract available


  444. AYDIN S, Personne Y, Newire E, Laverick R, et al
    Presence of Type I-F CRISPR/Cas systems is associated with antimicrobial susceptibility in Escherichia coli.
    J Antimicrob Chemother. 2017;72:2213-2218.
    PubMed     Abstract available


  445. MATSUMURA Y, Peirano G, Devinney R, Bradford PA, et al
    Genomic epidemiology of global VIM-producing Enterobacteriaceae.
    J Antimicrob Chemother. 2017;72:2249-2258.
    PubMed     Abstract available


  446. SVENSSON RJ, Gillespie SH, Simonsson USH
    Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods.
    J Antimicrob Chemother. 2017;72:2311-2319.
    PubMed     Abstract available


  447. LIVERMORE DM, Mushtaq S, Meunier D, Hopkins KL, et al
    Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles.
    J Antimicrob Chemother. 2017;72:2278-2289.
    PubMed     Abstract available


  448. BOTELHO J, Grosso F, Quinteira S, Mabrouk A, et al
    The complete nucleotide sequence of an IncP-2 megaplasmid unveils a mosaic architecture comprising a putative novel blaVIM-2-harbouring transposon in Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2017;72:2225-2229.
    PubMed     Abstract available


  449. LAGACE-WIENS PRS, Adam HJ, Laing NM, Baxter MR, et al
    Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential.
    J Antimicrob Chemother. 2017;72:2273-2277.
    PubMed     Abstract available


  450. CHATTERJEE S, Mondal A, Mitra S, Basu S, et al
    Acinetobacter baumannii transfers the blaNDM-1 gene via outer membrane vesicles.
    J Antimicrob Chemother. 2017;72:2201-2207.
    PubMed     Abstract available


  451. VARGAS-PALACIOS A, Meads DM, Twiddy M, Czoski Murray C, et al
    Cost-effectiveness of outpatient parenteral antibiotic therapy: a simulation modelling approach.
    J Antimicrob Chemother. 2017;72:2392-2400.
    PubMed     Abstract available


  452. SMITH NM, Bulman ZP, Sieron AO, Bulitta JB, et al
    Pharmacodynamics of dose-escalated 'front-loading' polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coli.
    J Antimicrob Chemother. 2017;72:2297-2303.
    PubMed     Abstract available


  453. DOUMITH M, Findlay J, Hirani H, Hopkins KL, et al
    Major role of pKpQIL-like plasmids in the early dissemination of KPC-type carbapenemases in the UK.
    J Antimicrob Chemother. 2017;72:2241-2248.
    PubMed     Abstract available


    July 2017
  454. FIRSOV AA, Alieva KN, Strukova EN, Golikova MV, et al
    Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.
    J Antimicrob Chemother. 2017 Jul 31. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: